Year |
Citation |
Score |
2019 |
Granata V, Fusco R, Maio F, Avallone A, Nasti G, Palaia R, Albino V, Grassi R, Izzo F, Petrillo A. Qualitative assessment of EOB-GD-DTPA and Gd-BT-DO3A MR contrast studies in HCC patients and colorectal liver metastases. Infectious Agents and Cancer. 14: 40. PMID 31798677 DOI: 10.1186/s13027-019-0264-3 |
0.3 |
|
2016 |
Bimonte S, Leongito M, Piccirillo M, de Angelis C, Pivonello C, Granata V, Izzo F. Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment. Infectious Agents and Cancer. 11: 38. PMID 27525037 DOI: 10.1186/s13027-016-0082-9 |
0.304 |
|
2015 |
Bimonte S, Barbieri A, Palaia R, Leongito M, Albino V, Piccirillo M, Arra C, Izzo F. An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma. Infectious Agents and Cancer. 10: 9. PMID 25755676 DOI: 10.1186/s13027-015-0004-2 |
0.305 |
|
2013 |
Costantini S, Capone F, Maio P, Guerriero E, Colonna G, Izzo F, Castello G. Cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma. Oncology Reports. 29: 2163-8. PMID 23564159 DOI: 10.3892/or.2013.2378 |
0.312 |
|
2002 |
Curley SA, Izzo F. Radiofrequency ablation of primary and metastatic liver tumors. Surgical Technology International. 10: 99-106. PMID 12384870 |
0.308 |
|
2000 |
Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Annals of Surgery. 232: 381-91. PMID 10973388 DOI: 10.1097/00000658-200009000-00010 |
0.305 |
|
Low-probability matches (unlikely to be authored by this person) |
2023 |
Santagata S, Rea G, Castaldo D, Napolitano M, Capiluongo A, D'Alterio C, Trotta AM, Ieranò C, Portella L, Di Maro S, Tatangelo F, Albino V, Guarino R, Cutolo C, Izzo F, et al. Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment. Hepatology International. PMID 37142825 DOI: 10.1007/s12072-023-10537-6 |
0.299 |
|
2018 |
Sangro B, Maini CL, Ettorre GM, Cianni R, Golfieri R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Van Buskirk M, Bilbao JI, Salvatori R, Giampalma E, Geatti O, Wilhelm K, ... ... Izzo F, et al. Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29516130 DOI: 10.1007/s00259-018-3968-5 |
0.298 |
|
2022 |
Cutolo C, Dell'Aversana F, Fusco R, Grazzini G, Chiti G, Simonetti I, Bruno F, Palumbo P, Pierpaoli L, Valeri T, Izzo F, Giovagnoni A, Grassi R, Miele V, Barile A, et al. Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know. Diagnostics (Basel, Switzerland). 12. PMID 35453938 DOI: 10.3390/diagnostics12040890 |
0.293 |
|
2023 |
Cutolo C, Fusco R, Simonetti I, De Muzio F, Grassi F, Trovato P, Palumbo P, Bruno F, Maggialetti N, Borgheresi A, Bruno A, Chiti G, Bicci E, Brunese MC, Giovagnoni A, ... ... Izzo F, et al. Imaging Features of Main Hepatic Resections: The Radiologist Challenging. Journal of Personalized Medicine. 13. PMID 36675795 DOI: 10.3390/jpm13010134 |
0.291 |
|
1998 |
Izzo F, Cremona F, Ruffolo F, Palaia R, Parisi V, Curley SA. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Annals of Surgery. 227: 513-8. PMID 9563539 DOI: 10.1097/00000658-199804000-00011 |
0.29 |
|
2005 |
Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Annals of Surgical Oncology. 12: 616-28. PMID 15965731 DOI: 10.1245/ASO.2005.06.011 |
0.289 |
|
2004 |
Curley SA, Izzo F, Abdalla E, Vauthey JN. Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Reviews. 23: 165-82. PMID 15000156 |
0.288 |
|
2020 |
Granata V, Palaia R, Albino V, Piccirillo M, Venanzio Setola S, Petrillo A, Izzo F. Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a case report. European Review For Medical and Pharmacological Sciences. 24: 7051-7057. PMID 32633399 DOI: 10.26355/eurrev_202006_21698 |
0.287 |
|
2012 |
Sangro B, Carpanese L, Cianni R, Gasparini D, Golfieri R, Ezziddin S, Kolligs FT, Izzo F. Assessment of radioembolization among patients who met the inclusion criteria for Sorafenib Hepatocellular Carcinoma Assessment Randomized Protocol (SHARP). Journal of Clinical Oncology. 30: e14654-e14654. DOI: 10.1200/JCO.2012.30.15_SUPPL.E14654 |
0.287 |
|
2003 |
Daniele B, De Sio I, Izzo F, Capuano G, Andreana A, Mazzanti R, Aiello A, Vallone P, Fiore F, Gaeta GB, Perrone F, Pignata S, Gallo C. Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study. Journal of Clinical Gastroenterology. 36: 63-7. PMID 12488711 DOI: 10.1097/00004836-200301000-00017 |
0.286 |
|
2014 |
D’Apolito O, Garofalo D, Gelzo M, Paris D, Melck D, Calemma R, Izzo F, Palmieri G, Castello G, Motta A, Corso G. Basic amino acids and dimethylarginines targeted metabolomics discriminates primary hepatocarcinoma from hepatic colorectal metastases Metabolomics. 10: 1026-1035. DOI: 10.1007/s11306-014-0641-2 |
0.283 |
|
2015 |
Catalano O, Izzo F, Vallone P, Sandomenico F, Albino V, Nunziata A, Fusco R, Petrillo A. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience. Acta Radiologica (Stockholm, Sweden : 1987). 56: 133-42. PMID 24523360 DOI: 10.1177/0284185114521108 |
0.283 |
|
2015 |
Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Arra C, Maiolino P, Izzo F, Tornesello ML, Aurisicchio L, Ciliberto G, Buonaguro FM, Buonaguro L. Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model. Cancer Immunology, Immunotherapy : Cii. 64: 1305-14. PMID 25944003 DOI: 10.1007/s00262-015-1698-0 |
0.282 |
|
2009 |
Gannon CJ, Izzo F, Aloia TA, Pignata S, Nasti G, Vallone P, Orlando R, Scordino F, Curley SA. Can hepatocellular cancer screening increase the proportion of long-term survivors? Hepato-Gastroenterology. 56: 1152-6. PMID 19760960 |
0.282 |
|
2009 |
Izzo F, Piccirillo M, Palaia R, Albino V, Di Giacomo R, Mastro AA. Management of colorectal liver metastases in patients with peritoneal carcinomatosis. Journal of Surgical Oncology. 100: 345-7. PMID 19697443 DOI: 10.1002/jso.21331 |
0.281 |
|
2020 |
Granata V, Fusco R, Venanzio Setola S, Sandomenico F, Luisa Barretta M, Belli A, Palaia R, Tatangelo F, Grassi R, Izzo F, Petrillo A. Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma. Radiology and Oncology. 54: 149-158. PMID 32463393 DOI: 10.2478/raon-2020-0029 |
0.279 |
|
2022 |
Granata V, Fusco R, De Muzio F, Cutolo C, Setola SV, Simonetti I, Dell'Aversana F, Grassi F, Bruno F, Belli A, Patrone R, Pilone V, Petrillo A, Izzo F. Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect. Journal of Clinical Medicine. 11. PMID 35628893 DOI: 10.3390/jcm11102766 |
0.277 |
|
2013 |
Izzo F, Piccirillo M, Albino V, Palaia R, Belli A, Granata V, Setola S, Fusco R, Petrillo A, Orlando R, Tosone G, Scordino F, Curley SA. Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 15: 985-90. PMID 23607636 DOI: 10.1111/hpb.12080 |
0.275 |
|
2019 |
Granata V, Fusco R, de Lutio di Castelguidone E, Avallone A, Palaia R, Delrio P, Tatangelo F, Botti G, Grassi R, Izzo F, Petrillo A. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection. Bmc Gastroenterology. 19: 129. PMID 31340755 DOI: 10.1186/s12876-019-1036-7 |
0.274 |
|
1997 |
Balch G, Izzo F, Chiao P, Klostergaard J, Curley SA. Activation of human Kupffer cells by thymostimulin (TP-1) to produce cytotoxicity against human hepatocellular cancer. Annals of Surgical Oncology. 4: 149-55. PMID 9084852 DOI: 10.1007/Bf02303798 |
0.274 |
|
2019 |
Granata V, Fusco R, Venanzio Setola S, Mattace Raso M, Avallone A, De Stefano A, Nasti G, Palaia R, Delrio P, Petrillo A, Izzo F. Liver radiologic findings of chemotherapy-induced toxicity in liver colorectal metastases patients. European Review For Medical and Pharmacological Sciences. 23: 9697-9706. PMID 31799635 DOI: 10.26355/eurrev_201911_19531 |
0.274 |
|
2003 |
Scaife CL, Curley SA, Izzo F, Marra P, Delrio P, Daniele B, Cremona F, Gershenwald JE, Chase JL, Lozano RD, Patt YZ, Fornage BD, Vauthey JN, Woodall ML, Gonzalez KB, et al. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Annals of Surgical Oncology. 10: 348-54. PMID 12734081 |
0.274 |
|
2011 |
Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Van Buskirk M, Bilbao JI, Ettorre GM, Salvatori R, Giampalma E, Geatti O, Wilhelm K, ... ... Izzo F, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Hepatology (Baltimore, Md.). 54: 868-78. PMID 21618574 DOI: 10.1002/hep.24451 |
0.274 |
|
2015 |
Izzo F, Palaia R, Albino V, Amore A, di Giacomo R, Piccirillo M, Leongito M, Nasto A, Granata V, Petrillo A, Lastoria S. Hepatocellular carcinoma and liver metastases: clinical data on a new dual-lumen catheter kit for surgical sealant infusion to prevent perihepatic bleeding and dissemination of cancer cells following biopsy and loco-regional treatments. Infectious Agents and Cancer. 10: 11. PMID 25897320 DOI: 10.1186/s13027-015-0006-0 |
0.27 |
|
2019 |
Izzo F, Granata V, Grassi R, Fusco R, Palaia R, Delrio P, Carrafiello G, Azoulay D, Petrillo A, Curley SA. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update. The Oncologist. PMID 31217342 DOI: 10.1634/theoncologist.2018-0337 |
0.269 |
|
2006 |
Pignata S, Gallo C, Daniele B, Elba S, Giorgio A, Capuano G, Adinolfi LE, De Sio I, Izzo F, Farinati F, Del Naja C, Stanzione M, Castiglione F, Marone G, Cuomo O, et al. Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). Critical Reviews in Oncology/Hematology. 59: 243-9. PMID 16916608 DOI: 10.1016/j.critrevonc.2006.01.002 |
0.267 |
|
1999 |
Izzo F, Cremona F, Delrio P, Leonardi E, Castello G, Pignata S, Daniele B, Curley SA. Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein. Annals of Surgical Oncology. 6: 178-85. PMID 10082044 DOI: 10.1007/s10434-999-0178-1 |
0.267 |
|
2015 |
Roayaie S, Jibara G, Tabrizian P, Park JW, Yang J, Yan L, Schwartz M, Han G, Izzo F, Chen M, Blanc JF, Johnson P, Kudo M, Roberts LR, Sherman M. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology (Baltimore, Md.). PMID 25678263 DOI: 10.1002/hep.27745 |
0.266 |
|
2013 |
Nasti G, Piccirillo MC, Izzo F, Ottaiano A, Albino V, Delrio P, Romano C, Giordano P, Lastoria S, Caracò C, de Lutio di Castelguidone E, Palaia R, Daniele G, Aloj L, Romano G, et al. Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial. British Journal of Cancer. 108: 1566-70. PMID 23558891 DOI: 10.1038/bjc.2013.140 |
0.266 |
|
2021 |
Engstrand J, Abreu de Carvalho LF, Aghayan D, Balakrishnan A, Belli A, Björnsson B, Dasari BVM, Detry O, Di Martino M, Edwin B, Erdmann J, Fristedt R, Fusai G, Gimenez-Maurel T, Hemmingsson O, ... ... Izzo F, et al. Liver resection and ablation for squamous cell carcinoma liver metastases. Bjs Open. 5. PMID 34426830 DOI: 10.1093/bjsopen/zrab060 |
0.265 |
|
2021 |
Granata V, Grassi R, Fusco R, Setola SV, Belli A, Piccirillo M, Pradella S, Giordano M, Cappabianca S, Brunese L, Grassi R, Petrillo A, Izzo F. Abbreviated MRI Protocol for the Assessment of Ablated Area in HCC Patients. International Journal of Environmental Research and Public Health. 18. PMID 33808466 DOI: 10.3390/ijerph18073598 |
0.265 |
|
2010 |
Nasti G, Ottaiano A, Berretta M, Delrio P, Izzo F, Cassata A, Romano C, Facchini G, Scala D, Mastro A, Romano G, Perri F, Iaffaioli RV. Pre-operative chemotherapy for colorectal cancer liver metastases: An update of recent clinical trials Cancer Chemotherapy and Pharmacology. 66: 209-218. PMID 20333385 DOI: 10.1007/s00280-010-1297-x |
0.265 |
|
2022 |
Tornesello ML, Tornesello AL, Starita N, Cerasuolo A, Izzo F, Buonaguro L, Buonaguro FM. Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data. Expert Opinion On Therapeutic Targets. 26: 767-780. PMID 36369706 DOI: 10.1080/14728222.2022.2147062 |
0.264 |
|
2013 |
De Giorgi V, Buonaguro L, Worschech A, Tornesello ML, Izzo F, Marincola FM, Wang E, Buonaguro FM. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis. Plos One. 8: e56153. PMID 23441164 DOI: 10.1371/journal.pone.0056153 |
0.263 |
|
2021 |
Granata V, Grassi R, Fusco R, Belli A, Cutolo C, Pradella S, Grazzini G, La Porta M, Brunese MC, De Muzio F, Ottaiano A, Avallone A, Izzo F, Petrillo A. Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma. Infectious Agents and Cancer. 16: 53. PMID 34281580 DOI: 10.1186/s13027-021-00393-0 |
0.262 |
|
2010 |
Capone F, Costantini S, Guerriero E, Calemma R, Napolitano M, Scala S, Izzo F, Castello G. Serum cytokine levels in patients with hepatocellular carcinoma. European Cytokine Network. 21: 99-104. PMID 20478763 DOI: 10.1684/ecn.2010.0192 |
0.262 |
|
1999 |
Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, Fiore F, Pignata S, Daniele B, Cremona F. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Annals of Surgery. 230: 1-8. PMID 10400029 DOI: 10.1097/00000658-199907000-00001 |
0.262 |
|
2003 |
Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Annals of Surgical Oncology. 10: 1059-69. PMID 14597445 DOI: 10.1245/Aso.2003.03.026 |
0.262 |
|
2017 |
Gentilini D, Scala S, Gaudenzi G, Garagnani P, Capri M, Cescon M, Grazi GL, Bacalini MG, Pisoni S, Dicitore A, Circelli L, Santagata S, Izzo F, Di Blasio AM, Persani L, et al. Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach. Oncotarget. PMID 28514750 DOI: 10.18632/oncotarget.17462 |
0.261 |
|
1999 |
Pearson AS, Izzo F, Fleming RYD, Ellis LM, Delrio P, Roh MS, Granchi J, Curley SA. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies American Journal of Surgery. 178: 592-599. PMID 10670879 DOI: 10.1016/S0002-9610(99)00234-2 |
0.261 |
|
2003 |
Vallone P, Gallipoli A, Izzo F, Fiore F, Delrio P. Local ablation procedures in primary liver tumors: Levovist US versus spiral CTto evaluate therapeutic results. Anticancer Research. 23: 5075-9. PMID 14981969 |
0.26 |
|
2013 |
Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics. 102: 74-83. PMID 23583669 DOI: 10.1016/j.ygeno.2013.04.001 |
0.259 |
|
2022 |
Granata V, Fusco R, De Muzio F, Cutolo C, Setola SV, Dell'Aversana F, Ottaiano A, Nasti G, Grassi R, Pilone V, Miele V, Brunese MC, Tatangelo F, Izzo F, Petrillo A. EOB-MR Based Radiomics Analysis to Assess Clinical Outcomes following Liver Resection in Colorectal Liver Metastases. Cancers. 14. PMID 35267544 DOI: 10.3390/cancers14051239 |
0.259 |
|
2023 |
Granata V, Fusco R, Setola SV, Galdiero R, Maggialetti N, Patrone R, Ottaiano A, Nasti G, Silvestro L, Cassata A, Grassi F, Avallone A, Izzo F, Petrillo A. Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics. Infectious Agents and Cancer. 18: 18. PMID 36927442 DOI: 10.1186/s13027-023-00495-x |
0.259 |
|
2009 |
Izzo F, Catino AM, Vogl TJ, Middleton M, Valle JW, Fiore F, Gadaleta CD, Pirotta RM, Martignoni M, Laffranchi B. Phase II trial of nemorubicin hydrocloride (nemorubicin) in combination with cisplatin (cDDP) in patients (pts) with hepatocellular carcinoma (HCC): First step results. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4593. PMID 27963115 DOI: 10.1200/jco.2009.27.15_suppl.4593 |
0.258 |
|
2013 |
Granata V, Petrillo M, Fusco R, Setola SV, de Lutio di Castelguidone E, Catalano O, Piccirillo M, Albino V, Izzo F, Petrillo A. Surveillance of HCC Patients after Liver RFA: Role of MRI with Hepatospecific Contrast versus Three-Phase CT Scan-Experience of High Volume Oncologic Institute. Gastroenterology Research and Practice. 2013: 469097. PMID 24324487 DOI: 10.1155/2013/469097 |
0.258 |
|
2011 |
Sangro B, Ettorre G, Cianni R, Gasparini D, Golfieri R, Ezzidin S, Kolligs F, Izzo F. 80 EUROPEAN NETWORK ON RADIOEMBOLISATION WITH 90Y-RESIN MICROSPHERES (ENRY) MULTICENTRE EVALUATION OF SURVIVAL, SAFETY AND LIVER FUNCTION FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) Journal of Hepatology. 54: S36. DOI: 10.1016/S0168-8278(11)60082-2 |
0.257 |
|
2015 |
Capone F, Guerriero E, Colonna G, Maio P, Mangia A, Marfella R, Paolisso G, Izzo F, Potenza N, Tomeo L, Castello G, Costantini S. The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes. Plos One. 10: e0134594. PMID 26226632 DOI: 10.1371/journal.pone.0134594 |
0.256 |
|
2023 |
Costantini S, Di Gennaro E, Capone F, De Stefano A, Nasti G, Vitagliano C, Setola SV, Tatangelo F, Delrio P, Izzo F, Avallone A, Budillon A. Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection. Frontiers in Oncology. 12: 1110104. PMID 36713567 DOI: 10.3389/fonc.2022.1110104 |
0.256 |
|
2023 |
Granata V, Fusco R, De Muzio F, Cutolo C, Grassi F, Brunese MC, Simonetti I, Catalano O, Gabelloni M, Pradella S, Danti G, Flammia F, Borgheresi A, Agostini A, Bruno F, ... ... Izzo F, et al. Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence. Biology. 12. PMID 36829492 DOI: 10.3390/biology12020213 |
0.255 |
|
2000 |
Ahmad SA, Bilimoria MM, Izzo F, Delrio P, Marra P, Baker TP, Porter GA, Ellis LM, Vauthey JN, Dhamotharan S, Curley SA. Hepatitis serology as a prognostic factor in patientswith hepatocellular carcinoma Gastroenterology. 118: A1036. DOI: 10.1016/S0016-5085(00)86292-7 |
0.254 |
|
2017 |
Gentile I, Buonomo AR, Scotto R, Zappulo E, Carriero C, Piccirillo M, Izzo F, Rizzo M, Cerasuolo D, Borgia G, Cavalcanti E. Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection. In Vivo (Athens, Greece). 31: 695-700. PMID 28652441 |
0.253 |
|
2016 |
Tornesello ML, Buonaguro L, Izzo F, Buonaguro FM. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections. Oncotarget. PMID 26943571 DOI: 10.18632/oncotarget.7837 |
0.253 |
|
2023 |
Granata V, Fusco R, Setola SV, Galdiero R, Maggialetti N, Patrone R, Ottaiano A, Nasti G, Silvestro L, Cassata A, Grassi F, Avallone A, Izzo F, Petrillo A. Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics. Infectious Agents and Cancer. 18: 28. PMID 37147694 DOI: 10.1186/s13027-023-00508-9 |
0.253 |
|
2004 |
Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, Scaife C, Raut C, Wolff R, Choi H, Loyer E, Vallone P, Fiore F, Scordino F, De Rosa V, ... ... Izzo F, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Annals of Surgery. 239: 450-8. PMID 15024305 DOI: 10.1097/01.sla.0000118373.31781.f2 |
0.253 |
|
2013 |
Piccirillo M, Granata V, Albino V, Palaia R, Setola SV, Petrillo A, Tatangelo F, Botti G, Foggia M, Izzo F. Can hepatocellular carcinoma (HCC) produce unconventional metastases? Four cases of extrahepatic HCC. Tumori. 99: e19-23. PMID 23549015 DOI: 10.1700/1248.13806 |
0.251 |
|
2022 |
Izzo F, Mason MC, Silberfein EJ, Massarweh NN, Hsu C, Tran Cao HS, Palaia R, Piccirillo M, Belli A, Patrone R, Fusco R, Granata V, Curley SA. Long-Term Survival and Curative-Intent Treatment in Hepatitis B or C Virus-Associated Hepatocellular Carcinoma Patients Diagnosed during Screening. Biology. 11. PMID 36358298 DOI: 10.3390/biology11111597 |
0.251 |
|
2017 |
Pezzuto F, Izzo F, Buonaguro L, Annunziata C, Tatangelo F, Botti G, Buonaguro F, Tornesello M. TERT promoter and CTNNB1 gene mutations represent cancer signatures specific for hepatitis B and hepatitis C related hepatocellular carcinoma Digestive and Liver Disease. 49: e27. DOI: 10.1016/J.DLD.2017.01.058 |
0.251 |
|
2023 |
Caponigro V, Tornesello AL, Merciai F, La Gioia D, Salviati E, Basilicata MG, Musella S, Izzo F, Megna AS, Buonaguro L, Sommella E, Buonaguro FM, Tornesello ML, Campiglia P. Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patients. Journal of Translational Medicine. 21: 918. PMID 38110968 DOI: 10.1186/s12967-023-04801-4 |
0.25 |
|
2021 |
Rocca A, Cipriani F, Belli G, Berti S, Boggi U, Bottino V, Cillo U, Cescon M, Cimino M, Corcione F, De Carlis L, Degiuli M, De Paolis P, De Rose AM, D'Ugo D, ... ... Izzo F, et al. The Italian Consensus on minimally invasive simultaneous resections for synchronous liver metastasis and primary colorectal cancer: A Delphi methodology. Updates in Surgery. PMID 34089501 DOI: 10.1007/s13304-021-01100-9 |
0.248 |
|
2011 |
Sangro B, Ettorre G, Cianni R, Gasparini D, Golfieri R, Ezzidin S, Kolligs F, Izzo F. 650 SURVIVAL AND TOLERABILITY FOLLOWING Y-RESIN MICROSPHERE RADIOEMBOLISATION IN PATIENTS WITH UNRESECTABLE BCLC STAGE C HEPATOCELLULAR CARCINOMA (HCC) Journal of Hepatology. 54: S262-S263. DOI: 10.1016/S0168-8278(11)60652-1 |
0.247 |
|
2022 |
Granata V, Fusco R, De Muzio F, Cutolo C, Setola SV, Dell' Aversana F, Ottaiano A, Avallone A, Nasti G, Grassi F, Pilone V, Miele V, Brunese L, Izzo F, Petrillo A. Contrast MR-Based Radiomics and Machine Learning Analysis to Assess Clinical Outcomes following Liver Resection in Colorectal Liver Metastases: A Preliminary Study. Cancers. 14. PMID 35267418 DOI: 10.3390/cancers14051110 |
0.246 |
|
2015 |
Granata V, Fusco R, Catalano O, Piccirillo M, De Bellis M, Izzo F, Petrillo A. Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings. Ajr. American Journal of Roentgenology. 204: 1000-7. PMID 25905934 DOI: 10.2214/AJR.14.12509 |
0.246 |
|
2013 |
Golfieri R, Bilbao JI, Carpanese L, Cianni R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Cappelli A, Rodriguez M, Ettorre GM, Saltarelli A, Geatti O, Ahmadzadehfar H, Haug AR, ... Izzo F, et al. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. Journal of Hepatology. 59: 753-61. PMID 23707371 DOI: 10.1016/j.jhep.2013.05.025 |
0.244 |
|
2017 |
Granata V, Fusco R, Avallone A, Catalano O, Filice F, Leongito M, Palaia R, Izzo F, Petrillo A. Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update. Infectious Agents and Cancer. 12: 23. PMID 28465718 DOI: 10.1186/s13027-017-0132-y |
0.242 |
|
2021 |
Pezzuto F, Izzo F, De Luca P, Biffali E, Buonaguro L, Tatangelo F, Buonaguro FM, Tornesello ML. Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma. Cancers. 13. PMID 34359670 DOI: 10.3390/cancers13153771 |
0.241 |
|
2015 |
Tafuto S, von Arx C, De Divitiis C, Maura CT, Palaia R, Albino V, Fusco R, Membrini M, Petrillo A, Granata V, Izzo F. Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases. International Journal of Surgery (London, England). 21: S78-82. PMID 26123385 DOI: 10.1016/j.ijsu.2015.04.095 |
0.24 |
|
2004 |
Izzo F, Marra P, Beneduce G, Castello G, Vallone P, De Rosa V, Cremona F, Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA, Ng C, Curley SA. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1815-22. PMID 15143074 DOI: 10.1200/JCO.2004.11.120 |
0.239 |
|
2015 |
Neve Polimeno M, Ierano C, D'Alterio C, Simona Losito N, Napolitano M, Portella L, Scognamiglio G, Tatangelo F, Maria Trotta A, Curley S, Costantini S, Liuzzi R, Izzo F, Scala S. CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not. Cellular & Molecular Immunology. 12: 474-82. PMID 25363530 DOI: 10.1038/cmi.2014.102 |
0.239 |
|
2020 |
Belli A, Piccirillo M, Avallone A, Budillon A, Palaia R, Albino V, Piccirillo M, Patrone R, Izzo F. Outcome Prediction of Metastatic Colorectal Cancer Patients Undergoing Liver Resection after Neoadjuvant Chemotheraphy by Analyzing Serum Metabolomics and Cytokinomics. European Journal of Surgical Oncology. 46: e94. DOI: 10.1016/j.ejso.2019.11.228 |
0.238 |
|
2021 |
Tornesello AL, Reimer U, Holenya P, Knaute T, Pezzuto F, Izzo F, Buonaguro L, Megna AS, Buonaguro FM, Tornesello ML. Profiling the HCV immune response in patients with chronic liver diseases and hepatocellular carcinoma by peptide microarray analysis. Current Medicinal Chemistry. PMID 34736375 DOI: 10.2174/0929867328666211104093718 |
0.238 |
|
2008 |
Fiore F, Gadaleta CD, Granetto C, Middleton M, Sorio R, Labianca R, Valota O, Pirotta RN, Battaglia R, Izzo F. Nemorubicin hydrochloride (nemorubicin) in combination with cisplatin (cDDP): Phase I in patients (pts) with hepatocellular carcinoma (HCC) Journal of Clinical Oncology. 26: 2572-2572. DOI: 10.1200/jco.2008.26.15_suppl.2572 |
0.238 |
|
2018 |
Granata V, Fusco R, Avallone A, Catalano O, Piccirillo M, Palaia R, Nasti G, Petrillo A, Izzo F. A radiologist's point of view in the presurgical and intraoperative setting of colorectal liver metastases. Future Oncology (London, England). PMID 30084273 DOI: 10.2217/fon-2018-0080 |
0.237 |
|
2002 |
Ahmad SA, Bilimoria MM, Wang X, Izzo F, Delrio P, Marra P, Baker TP, Porter GA, Ellis LM, Vauthey JN, Dhamotharan S, Curley SA. Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 5: 468-76. PMID 11985997 DOI: 10.1016/S1091-255X(01)80084-6 |
0.237 |
|
1995 |
Curley SA, Izzo F, Gallipoli A, de Bellis M, Cremona F, Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Annals of Surgery. 222: 375-80; discussion 3. PMID 7677466 DOI: 10.1097/00000658-199509000-00014 |
0.236 |
|
2016 |
Pezzuto F, Izzo F, Buonaguro L, Annunziata C, Tatangelo F, Botti G, Buonaguro FM, Tornesello ML. Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma. Oncotarget. PMID 27276713 DOI: 10.18632/oncotarget.9801 |
0.236 |
|
2018 |
Granata V, Fusco R, Filice S, Catalano O, Piccirillo M, Palaia R, Izzo F, Petrillo A. The current role and future prospectives of functional parameters by diffusion weighted imaging in the assessment of histologic grade of HCC. Infectious Agents and Cancer. 13: 23. PMID 29988667 DOI: 10.1186/s13027-018-0194-5 |
0.233 |
|
2022 |
Cutolo C, De Muzio F, Fusco R, Simonetti I, Belli A, Patrone R, Grassi F, Dell'Aversana F, Pilone V, Petrillo A, Izzo F, Granata V. Imaging Features of Post Main Hepatectomy Complications: The Radiologist Challenging. Diagnostics (Basel, Switzerland). 12. PMID 35741133 DOI: 10.3390/diagnostics12061323 |
0.23 |
|
2022 |
Granata V, Fusco R, De Muzio F, Cutolo C, Setola SV, Grassi R, Grassi F, Ottaiano A, Nasti G, Tatangelo F, Pilone V, Miele V, Brunese MC, Izzo F, Petrillo A. Radiomics textural features by MR imaging to assess clinical outcomes following liver resection in colorectal liver metastases. La Radiologia Medica. PMID 35347583 DOI: 10.1007/s11547-022-01477-6 |
0.23 |
|
2023 |
Tortora R, Farella N, Morisco F, Coppola C, Izzo F, Salomone Megna A, Federico A, Messina V, Nardone G, Piai G, Ragone E, Adinolfi LE, D'Adamo G, Stanzione M, Francica G, et al. Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology. PMID 37115974 DOI: 10.1097/MEG.0000000000002549 |
0.23 |
|
2022 |
Patrone R, Izzo F, Palaia R, Granata V, Nasti G, Ottaiano A, Pasta G, Belli A. Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review. World Journal of Gastrointestinal Oncology. 13: 2203-2215. PMID 35070052 DOI: 10.4251/wjgo.v13.i12.2203 |
0.228 |
|
2013 |
Izzo F, Albino V, Palaia R, Piccirillo M, Nasto A, Carbone G, Capano R, Tatangelo F, Granata V. Thermal Ablation of Extended Liver Cancers: Assessment of Two New Bipolar Needle Electrodes European Journal of Inflammation. 11: 877-882. DOI: 10.1177/1721727X1301100331 |
0.227 |
|
2010 |
Glazer ES, Piccirillo M, Albino V, Di Giacomo R, Palaia R, Mastro AA, Beneduce G, Castello G, De Rosa V, Petrillo A, Ascierto PA, Curley SA, Izzo F. Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2220-6. PMID 20351325 DOI: 10.1200/JCO.2009.26.7765 |
0.227 |
|
2022 |
Granata V, Fusco R, Setola SV, De Muzio F, Dell' Aversana F, Cutolo C, Faggioni L, Miele V, Izzo F, Petrillo A. CT-Based Radiomics Analysis to Predict Histopathological Outcomes Following Liver Resection in Colorectal Liver Metastases. Cancers. 14. PMID 35406419 DOI: 10.3390/cancers14071648 |
0.227 |
|
2016 |
Bimonte S, Leongito M, Barbieri A, Del Vecchio V, Falco M, Giudice A, Palaia R, Albino V, Di Giacomo R, Petrillo A, Granata V, Izzo F. The Therapeutic Targets of miRNA in Hepatic Cancer Stem Cells. Stem Cells International. 2016: 1065230. PMID 27118975 DOI: 10.1155/2016/1065230 |
0.227 |
|
2016 |
Kutscher S, Accolla R, Ma YT, Heidenreich R, Izzo F, Koenigsrainer A, Loeffler M, Mueller P, Mayer A, Rammensee H, Sangro B, Francque S, Valmori D, Weinschenk T, Singh-Jasuja H, et al. Abstract 2354: Cancer vaccine development for hepatocellular carcinoma - HEPAVAC Cancer Research. 76: 2354-2354. DOI: 10.1158/1538-7445.Am2016-2354 |
0.226 |
|
2017 |
Granata V, Fusco R, Catalano O, Filice S, Avallone A, Piccirillo M, Leongito M, Palaia R, Grassi R, Izzo F, Petrillo A. Uncommon Neoplasms of the biliary tract: Radiological Findings. The British Journal of Radiology. 20160561. PMID 28731820 DOI: 10.1259/bjr.20160561 |
0.226 |
|
2020 |
Ottaiano A, Caraglia M, Di Mauro A, Botti G, Lombardi A, Galon J, Luce A, D'Amore L, Perri F, Santorsola M, Hermitte F, Savarese G, Tatangelo F, Granata V, Izzo F, et al. Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer. Cancers. 12. PMID 33096795 DOI: 10.3390/cancers12103073 |
0.225 |
|
2016 |
Granata V, Fusco R, Reginelli A, Roberto L, Granata F, Rega D, Rotondo A, Grassi R, Izzo F, Petrillo A. Radiological assessment of anal cancer: an overview and update. Infectious Agents and Cancer. 11: 52. PMID 27752279 DOI: 10.1186/s13027-016-0100-y |
0.225 |
|
2020 |
Granata V, Fusco R, Amato DM, Albino V, Patrone R, Izzo F, Petrillo A. Beyond the vascular profile: conventional DWI, IVIM and kurtosis in the assessment of hepatocellular carcinoma. European Review For Medical and Pharmacological Sciences. 24: 7284-7293. PMID 32706066 DOI: 10.26355/eurrev_202007_21883 |
0.225 |
|
2016 |
Yang J, Mara K, Harmsen W, Therneau T, Peck M, Stauber R, Degos F, Blanc J, Leroy V, Trinchet J, Duvoux C, Assenat E, Klinker H, Schott E, Colombo M, ... Izzo F, et al. Validation of Mesiah Score System in Patients with Hepatocellular Carcinoma Journal of Hepatology. 64: S330-S331. DOI: 10.1016/S0168-8278(16)00461-X |
0.225 |
|
2013 |
Melucci E, Cosimelli M, Carpanese L, Pizzi G, Izzo F, Fiore F, Golfieri R, Giampalma E, Sperduti I, Ercolani C, Sciuto R, Mancini R, Garufi C, Diodoro MG, Mottolese M, et al. Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheres. Journal of Experimental & Clinical Cancer Research : Cr. 32: 13. PMID 23497522 DOI: 10.1186/1756-9966-32-13 |
0.224 |
|
2016 |
Granata V, Fusco R, Catalano O, Setola SV, de Lutio di Castelguidone E, Piccirillo M, Palaia R, Grassi R, Granata F, Izzo F, Petrillo A. Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update. Infectious Agents and Cancer. 11: 57. PMID 27891175 DOI: 10.1186/s13027-016-0105-6 |
0.224 |
|
2023 |
Di Girolamo E, Belli A, Ottaiano A, Granata V, Borzillo V, Tarotto L, Tatangelo F, Palaia R, Civiletti C, Piccirillo M, D'Angelo V, Fiore F, Marone P, Nasti G, Izzo F, et al. Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review. Frontiers in Oncology. 13: 1077794. PMID 37324013 DOI: 10.3389/fonc.2023.1077794 |
0.223 |
|
2012 |
Izzo F, Colombo M, Leroy V, Blanc J, Johnson P, Fenwick S, Stal P, Assenat E, Matilla A, Pascual Bartolome S, Bourcier V, Degos F, Huang B, Wagner S, Orsini L. 719 OBSERVATIONS OF HEPATOCELLULAR CARCINOMA (HCC) MANAGEMENT PATTERNS FROM THE GLOBAL HCC BRIDGE STUDY: SECOND INTERIM ANALYSIS OF THE EUROPEAN (EU) COHORT Journal of Hepatology. 56: S284. DOI: 10.1016/S0168-8278(12)60732-6 |
0.223 |
|
2018 |
Abou-Alfa G, Qin S, Ryoo BY, Lu SN, Yen CJ, Feng YH, Lim HY, Izzo F, Colombo M, Sarker D, Bolondi L, Vaccaro G, Harris WP, Chen Z, Hubner RA, et al. ADI-PEG 20 Plus Best Supportive Care versus Placebo Plus Best Supportive Care in Patients with Advanced Hepatocellular Carcinoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29659672 DOI: 10.1093/annonc/mdy101 |
0.223 |
|
2016 |
Buonaguro L, Kutscher S, Accolla R, Ma YT, Heidenreich R, Izzo F, Koenigsrainer A, Loeffler M, Mueller P, Mayer A, Rammensee H, Sangro B, Francque S, Valmori D, Weinschenk T, et al. Abstract A115: Cancer vaccine development for hepatocellular carcinoma – HEPAVAC Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A115 |
0.222 |
|
1997 |
Curley SA, Davidson BS, Fleming RY, Izzo F, Stephens LC, Tinkey P, Cromeens D. Laparoscopically guided bipolar radiofrequency ablation of areas of porcine liver. Surgical Endoscopy. 11: 729-33. PMID 9214320 DOI: 10.1007/s004649900437 |
0.222 |
|
2020 |
Granata V, Fusco R, Avallone A, Cassata A, Palaia R, Delrio P, Grassi R, Tatangelo F, Grazzini G, Izzo F, Petrillo A. Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting. Plos One. 15: e0241431. PMID 33211702 DOI: 10.1371/journal.pone.0241431 |
0.222 |
|
2022 |
Granata V, Fusco R, De Muzio F, Cutolo C, Setola SV, Dell'Aversana F, Belli A, Romano C, Ottaiano A, Nasti G, Avallone A, Miele V, Tatangelo F, Petrillo A, Izzo F. Magnetic Resonance Features of Liver Mucinous Colorectal Metastases: What the Radiologist Should Know. Journal of Clinical Medicine. 11. PMID 35456314 DOI: 10.3390/jcm11082221 |
0.221 |
|
1996 |
Davidson BS, Izzo F, Chase JL, DuBrow RA, Patt Y, Hohn DC, Curley SA. Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity. American Journal of Surgery. 172: 244-7. PMID 8862076 DOI: 10.1016/S0002-9610(96)00159-6 |
0.221 |
|
2019 |
Granata V, Fusco R, Setola SV, Picone C, Vallone P, Belli A, Incollingo P, Albino V, Tatangelo F, Izzo F, Petrillo A. Microvascular invasion and grading in hepatocellular carcinoma: correlation with major and ancillary features according to LIRADS. Abdominal Radiology (New York). PMID 31089780 DOI: 10.1007/s00261-019-02056-6 |
0.22 |
|
2002 |
Perrone F, Gallo C, Daniele B, Gaeta GB, Izzo F, Capuano G, Adinolfi LE, Mazzanti R, Farinati F, Elba S, Piai G, Calandra M, Stanzione M, Mattera D, Aiello A, et al. Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial. Current Pharmaceutical Design. 8: 1013-9. PMID 11945148 DOI: 10.2174/1381612024607063 |
0.218 |
|
2022 |
Löffler MW, Gori S, Izzo F, Mayer-Mokler A, Ascierto P, Königsrainer A, Ma YT, Sangro B, Francque S, Vonghia L, Inno A, Avallone A, Ludwig J, Alcoba DD, Flohr C, et al. Phase I/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35421231 DOI: 10.1158/1078-0432.CCR-21-4424 |
0.218 |
|
2023 |
Granata V, Fusco R, De Muzio F, Brunese MC, Setola SV, Ottaiano A, Cardone C, Avallone A, Patrone R, Pradella S, Miele V, Tatangelo F, Cutolo C, Maggialetti N, Caruso D, ... Izzo F, et al. Radiomics and machine learning analysis by computed tomography and magnetic resonance imaging in colorectal liver metastases prognostic assessment. La Radiologia Medica. 128: 1310-1332. PMID 37697033 DOI: 10.1007/s11547-023-01710-w |
0.217 |
|
2000 |
Montella M, Crispo A, Izzo F, Ronga D, Tamburini M, De Marco M, Tridente V, Desicato S, Fabbrocini G, Cuomo O. HCV and hepatocellular carcinoma: A case-control study in an area of hyperendemicity. International Journal of Molecular Medicine. 6: 571-4. PMID 11029526 DOI: 10.3892/IJMM.6.5.571 |
0.217 |
|
1997 |
Cremona F, Izzo F, Ruffolo F, Palaia R, Parisi V. Adjuvant therapy for resectable colorectal carcinoma with 5-fluorouracil portal vein infusion. Journal of Chemotherapy (Florence, Italy). 9: 140-1. PMID 9176762 DOI: 10.1179/JOC.1997.9.2.140 |
0.215 |
|
2003 |
Izzo F. Other thermal ablation techniques: microwave and interstitial laser ablation of liver tumors. Annals of Surgical Oncology. 10: 491-7. PMID 12794014 |
0.213 |
|
2015 |
Granata V, Catalano O, Fusco R, Tatangelo F, Rega D, Nasti G, Avallone A, Piccirillo M, Izzo F, Petrillo A. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging. Abdominal Imaging. 40: 2364-71. PMID 26105523 DOI: 10.1007/s00261-015-0488-7 |
0.213 |
|
2008 |
Izzo F, Di Giacomo R, Falco P, Piccirillo M, Iodice R, Orlando AP, Aprea P, Cremona F, Di Marzo M, Idà DN, Mastro AA, Curley SA. Efficacy of a haemostatic matrix for the management of bleeding in patients undergoing liver resection: results from 237 cases. Current Medical Research and Opinion. 24: 1011-5. PMID 18291065 DOI: 10.1185/030079908X280392 |
0.213 |
|
2002 |
Curley SA, Izzo F. Radiofrequency ablation of primary and metastatic hepatic malignancies. International Journal of Clinical Oncology. 7: 72-81. PMID 12018113 DOI: 10.1007/s101470200010 |
0.213 |
|
2016 |
Albino V, Izzo F, Palaia R, Di Giacomo R, Piccirillo M, Leongito M, Nasti G, Aloj L, Caracò C, Lastoria S. Neoadjuvant folfiri + bevacizumab in patients with resectable liver metastases from colo-rectal cancer: Results from a phase 2 trial and comparative analysis of early PET/CT scan vs recist criteria in predicting outcome European Journal of Surgical Oncology (Ejso). 42: S210. DOI: 10.1016/J.EJSO.2016.04.034 |
0.212 |
|
2016 |
Mayer-Mokler A, Accolla R, Ma YT, Heidenreich R, Izzo F, Koenigsrainer A, Loeffler M, Flohr C, Mueller P, Kutscher S, Rammensee H, Sangro B, Francque S, Valmori D, Weinschenk T, et al. Abstract A043: Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant®): HEPAVAC Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-A043 |
0.212 |
|
2021 |
Patrone R, Granata V, Belli A, Palaia R, Albino V, Piccirillo M, Fusco R, Tatangelo F, Nasti G, Avallone A, Izzo F. The safety and efficacy of Glubran 2 as biliostatic agent in liver resection. Infectious Agents and Cancer. 16: 19. PMID 33726798 DOI: 10.1186/s13027-021-00358-3 |
0.211 |
|
2020 |
Granata V, Grassi R, Fusco R, Setola SV, Palaia R, Belli A, Miele V, Brunese L, Grassi R, Petrillo A, Izzo F. Assessment of Ablation Therapy in Pancreatic Cancer: The Radiologist's Challenge. Frontiers in Oncology. 10: 560952. PMID 33330028 DOI: 10.3389/fonc.2020.560952 |
0.21 |
|
2012 |
Buonaguro FM, Tornesello ML, Izzo F, Buonaguro L. Oncolytic virus therapies. Pharmaceutical Patent Analyst. 1: 621-7. PMID 24236929 DOI: 10.4155/ppa.12.65 |
0.21 |
|
2006 |
Franceschi S, Montella M, Polesel J, La Vecchia C, Crispo A, Dal Maso L, Casarin P, Izzo F, Tommasi LG, Chemin I, Trépo C, Crovatto M, Talamini R. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 683-9. PMID 16614109 DOI: 10.1158/1055-9965.EPI-05-0702 |
0.21 |
|
2016 |
Granata V, de Lutio di Castelguidone E, Fusco R, Catalano O, Piccirillo M, Palaia R, Izzo F, Gallipoli AD, Petrillo A. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area. La Radiologia Medica. 121: 122-31. PMID 26345332 DOI: 10.1007/s11547-015-0582-5 |
0.207 |
|
1997 |
Izzo F, Cremona F, Ruffolo F, Palaia R, Parisi V, Curley S. Detection of hepatocellular cancer during screening of 1125 patients with chronic hepatitis virus infection. Journal of Chemotherapy (Florence, Italy). 9: 151-2. PMID 9176768 DOI: 10.1179/JOC.1997.9.2.151 |
0.207 |
|
2017 |
Guarino M, Tortora R, de Stefano G, Coppola C, Morisco F, Megna AS, Izzo F, Nardone G, Piai G, Adinolfi LE, D'Adamo G, Gaeta GB, Messina V, Francica G, De Girolamo V, et al. Adherence to Barcelona Clinic Liver Cancer guidelines in field-practice: results of Progetto Epatocarcinoma Campania. Journal of Gastroenterology and Hepatology. PMID 28994145 DOI: 10.1111/jgh.14013 |
0.205 |
|
2006 |
Talamini R, Polesel J, Montella M, Dal Maso L, Crispo A, Tommasi LG, Izzo F, Crovatto M, La Vecchia C, Franceschi S. Food groups and risk of hepatocellular carcinoma: A multicenter case-control study in Italy. International Journal of Cancer. Journal International Du Cancer. 119: 2916-21. PMID 16998792 DOI: 10.1002/ijc.22267 |
0.204 |
|
2006 |
Vallone P, Catalano O, Izzo F, Siani A. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Cardiovascular and Interventional Radiology. 29: 544-51. PMID 16528626 DOI: 10.1007/s00270-005-0173-2 |
0.204 |
|
2019 |
Granata V, Fusco R, Reginelli A, Delrio P, Selvaggi F, Grassi R, Izzo F, Petrillo A. Diffusion kurtosis imaging in patients with locally advanced rectal cancer: current status and future perspectives. The Journal of International Medical Research. 300060519827168. PMID 31032670 DOI: 10.1177/0300060519827168 |
0.204 |
|
2013 |
Izzo F, Vogl TJ, Gadaleta-Caldarola G, Middleton MR, Valle JW, Hammerstingl R, Gadaleta CD, Martignoni M, Petroccione A, Mariani M, Davite C, Fiore F. Phase II trial of nemorubicin hydrochloride (N) in combination with cisplatin (cDDP) administered by intra-hepatic artery (IHA) in patients (pts) with hepatocellular carcinoma (HCC): Final results. Journal of Clinical Oncology. 31: e15061-e15061. DOI: 10.1200/JCO.2013.31.15_SUPPL.E15061 |
0.203 |
|
2017 |
Granata V, Fusco R, Avallone A, Filice F, Tatangelo F, Piccirillo M, Grassi R, Izzo F, Petrillo A. Critical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: Lights and shadows. Oncotarget. 8: 51224-51237. PMID 28881643 DOI: 10.18632/oncotarget.17227 |
0.203 |
|
2017 |
Granata V, Fusco R, Avallone A, Filice F, Tatangelo F, Piccirillo M, Grassi R, Izzo F, Petrillo A. Critical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: Lights and shadows. Oncotarget. PMID 28472767 DOI: 10.18632/oncotarget.17227 |
0.203 |
|
2001 |
Fiore F, Vallone P, Ricchi P, Tambaro R, Daniele B, Sandomenico F, De Vivo R, Civiletti C, Izzo F, Pignata S, Ziviello M. Levovist-enhanced Doppler sonography versus spiral computed tomography to evaluate response to percutaneous ethanol injection in hepatocellular carcinoma. Journal of Clinical Gastroenterology. 31: 164-8. PMID 10993437 DOI: 10.1097/00004836-200009000-00017 |
0.202 |
|
2004 |
Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Danielle B, Vallone P, Fornage B, Curley SA. Significant long-term survival in unresectable hepatocellular carcinoma treated with radiofrequency ablation Annals of Surgical Oncology. 11: S73-S73. DOI: 10.1007/BF02524040 |
0.202 |
|
2012 |
Colombino M, Sperlongano P, Izzo F, Tatangelo F, Botti G, Lombardi A, Accardo M, Tarantino L, Sordelli I, Agresti M, Abbruzzese A, Caraglia M, Palmieri G. BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy. Cell Death & Disease. 3: e259. PMID 22258409 DOI: 10.1038/cddis.2011.136 |
0.202 |
|
2022 |
Granata V, Fusco R, De Muzio F, Cutolo C, Setola SV, Dell'Aversana F, Grassi F, Belli A, Silvestro L, Ottaiano A, Nasti G, Avallone A, Flammia F, Miele V, Tatangelo F, ... Izzo F, et al. Radiomics and machine learning analysis based on magnetic resonance imaging in the assessment of liver mucinous colorectal metastases. La Radiologia Medica. PMID 35653011 DOI: 10.1007/s11547-022-01501-9 |
0.202 |
|
2015 |
Avallone A, Piccirillo MC, Aloj L, Nasti G, Delrio P, Izzo F, Di Gennaro E, Tatangelo F, Granata V, Cavalcanti E, Maiolino P, Bianco F, Aprea P, De Bellis M, Pecori B, et al. A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme). Bmc Cancer. 16: 69. PMID 26857924 DOI: 10.1186/s12885-016-2102-y |
0.201 |
|
2022 |
Rega D, Granata V, Petrillo A, Pace U, Di Marzo M, Fusco R, D'Alessio V, Nasti G, Romano C, Avallone A, Ravo V, Tatangelo F, Maiolino P, Palaia R, Izzo F, et al. Electrochemotherapy of Primary Colon Rectum Cancer and Local Recurrence: Case Report and Prospective Analysis. Journal of Clinical Medicine. 11. PMID 35628872 DOI: 10.3390/jcm11102745 |
0.201 |
|
2021 |
Granata V, Fusco R, Salati S, Petrillo A, Di Bernardo E, Grassi R, Palaia R, Danti G, La Porta M, Cadossi M, Gašljević G, Sersa G, Izzo F. A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response. International Journal of Environmental Research and Public Health. 18. PMID 34073865 DOI: 10.3390/ijerph18115592 |
0.201 |
|
2021 |
Patrone R, Velotti N, Masone S, Conzo A, Flagiello L, Cacciatore C, Filardo M, Granata V, Izzo F, Testa D, Avenia S, Sanguinetti A, Polistena A, Conzo G. Management of Low-Risk Thyroid Cancers: Is Active Surveillance a Valid Option? A Systematic Review of the Literature. Journal of Clinical Medicine. 10. PMID 34441866 DOI: 10.3390/jcm10163569 |
0.201 |
|
2020 |
Alvaro D, Hassan C, Cardinale V, Carpino G, Fabris L, Gringeri E, Granata V, Mutignani M, Morement H, Giuliante F, Guglielmi A, Ridola L, Marzioni M, Grazi G, Guido M, ... ... Izzo F, et al. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 32893173 DOI: 10.1016/j.dld.2020.06.045 |
0.199 |
|
2017 |
Granata V, Fusco R, Setola SV, Piccirillo M, Leongito M, Palaia R, Granata F, Lastoria S, Izzo F, Petrillo A. Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy. World Journal of Gastroenterology. 23: 4767-4778. PMID 28765698 DOI: 10.3748/wjg.v23.i26.4767 |
0.198 |
|
2020 |
Avallone A, Piccirillo MC, Di Gennaro E, Romano C, Calabrese F, Roca MS, Tatangelo F, Granata V, Cassata A, Cavalcanti E, Maurea N, Maiolino P, Silvestro L, De Stefano A, Giuliani F, ... ... Izzo F, et al. Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with -mutated metastatic colorectal cancer: the REVOLUTION study protocol. Therapeutic Advances in Medical Oncology. 12: 1758835920929589. PMID 32849914 DOI: 10.1177/1758835920929589 |
0.198 |
|
2016 |
Bimonte S, Leongito M, Granata V, Barbieri A, Vecchio VD, Falco M, Nasto A, Albino V, Piccirillo M, Palaia R, Amore A, Giacomo RD, Lastoria S, Setola SV, Fusco R, ... ... Izzo F, et al. Electrochemotherapy in pancreatic adenocarcinoma treatment: pre-clinical and clinical studies. Radiology and Oncology. 50: 14-20. PMID 32887201 DOI: 10.1515/raon-2016-0003 |
0.198 |
|
2014 |
Granata V, Fusco R, Piccirillo M, Palaia R, Lastoria S, Petrillo A, Izzo F. Feasibility and Safety of Intraoperative Electrochemotherapy in Locally Advanced Pancreatic Tumor: A Preliminary Experience European Journal of Inflammation. 12: 467-477. DOI: 10.1177/1721727X1401200308 |
0.198 |
|
2023 |
Granata V, Fusco R, Setola SV, Galdiero R, Maggialetti N, Silvestro L, De Bellis M, Di Girolamo E, Grazzini G, Chiti G, Brunese MC, Belli A, Patrone R, Palaia R, Avallone A, ... ... Izzo F, et al. Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence. Cancers. 15. PMID 36672301 DOI: 10.3390/cancers15020351 |
0.197 |
|
2021 |
Izzo F, Granata V, Fusco R, D'Alessio V, Petrillo A, Lastoria S, Piccirillo M, Albino V, Belli A, Nasti G, Avallone A, Patrone R, Grassi F, Leongito M, Palaia R. A Multicenter Randomized Controlled Prospective Study to Assess Efficacy of Laparoscopic Electrochemotherapy in the Treatment of Locally Advanced Pancreatic Cancer. Journal of Clinical Medicine. 10. PMID 34501459 DOI: 10.3390/jcm10174011 |
0.196 |
|
2016 |
Bimonte S, Barbieri A, Leongito M, Piccirillo M, Giudice A, Pivonello C, de Angelis C, Granata V, Palaia R, Izzo F. Curcumin AntiCancer Studies in Pancreatic Cancer. Nutrients. 8. PMID 27438851 DOI: 10.3390/nu8070433 |
0.196 |
|
2016 |
Abou-Alfa GK, Qin S, Ryoo B, Lu S, Yen C, Feng Y, Lim HY, Izzo F, Colombo M, Sarker D, Bolondi L, Vaccaro GM, Harris WP, Chen Z, Hubner R, et al. Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC). Journal of Clinical Oncology. 34: 4017-4017. DOI: 10.1200/JCO.2016.34.15_SUPPL.4017 |
0.196 |
|
2014 |
Izzo F, Palaia R, Albino V, Di Giacomo R, Amore A, Saponara R, Leongito M, Setola S, Granata V, Petrillo A. 330. A surgical glue, cyanoacrylate-based, for the prevention of bilomas post major liver resection European Journal of Surgical Oncology (Ejso). 40: S130. DOI: 10.1016/J.EJSO.2014.08.320 |
0.195 |
|
2007 |
Montella M, Polesel J, La Vecchia C, Dal Maso L, Crispo A, Crovatto M, Casarin P, Izzo F, Tommasi LG, Talamini R, Franceschi S. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. International Journal of Cancer. Journal International Du Cancer. 120: 1555-9. PMID 17205531 DOI: 10.1002/ijc.22509 |
0.195 |
|
2010 |
Izzo F, Piccirillo M, Albino V, Botti G, Foggia M, Iodice R, Pagano F, Piccirillo G, Tornillo L, Delrio P. Case report: appearance of an intestinal metastasis from intrahepatic cholangiocarcinoma occurring 5 years after resection of the primary tumor. European Journal of Gastroenterology & Hepatology. 22: 892-4. PMID 19550345 DOI: 10.1097/MEG.0b013e32832eb62b |
0.195 |
|
2020 |
Granata V, Grassi R, Fusco R, Izzo F, Brunese L, Delrio P, Avallone A, Pecori B, Petrillo A. Current status on response to treatment in locally advanced rectal cancer: what the radiologist should know. European Review For Medical and Pharmacological Sciences. 24: 12050-12062. PMID 33336723 DOI: 10.26355/eurrev_202012_23994 |
0.194 |
|
2012 |
Bruix J, Izzo F, Crocetti L, Vilgrain V, Abdel-Rehim M, Bianchi L, Ricke J, Pech M, Lencioni R. 1408 IRREVERSIBLE ELECTROPORATION FOR THE TREATMENT OF EARLY-STAGE HEPATOCELLULAR CARCINOMA. A PROSPECTIVE MULTICENTER PHASE 2 STUDY ASSESSING SAFETY AND EFFICACY Journal of Hepatology. 56: S554. DOI: 10.1016/S0168-8278(12)61419-6 |
0.194 |
|
2023 |
Famularo S, Cillo U, Lauterio A, Donadon M, Vitale A, Serenari M, Cipriani F, Fazio F, Giuffrida M, Ardito F, Dominioni T, Garancini M, Lai Q, Nicolini D, Molfino S, ... ... Izzo F, et al. Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenario. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. PMID 37357112 DOI: 10.1016/j.hpb.2023.06.004 |
0.193 |
|
2010 |
Cosimelli M, Golfieri R, Cagol PP, Carpanese L, Sciuto R, Maini CL, Mancini R, Sperduti I, Pizzi G, Diodoro MG, Perrone M, Giampalma E, Angelelli B, Fiore F, Lastoria S, ... ... Izzo F, et al. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases. British Journal of Cancer. 103: 324-31. PMID 20628388 DOI: 10.1038/sj.bjc.6605770 |
0.193 |
|
2018 |
Fusco R, Granata V, Rega D, Russo C, Pace U, Pecori B, Tatangelo F, Botti G, Izzo F, Cascella M, Avallone A, Delrio P, Petrillo A. Morphological and functional features prognostic factor of magnetic resonance imaging in locally advanced rectal cancer. Acta Radiologica (Stockholm, Sweden : 1987). 284185118803783. PMID 30286607 DOI: 10.1177/0284185118803783 |
0.193 |
|
2016 |
Bimonte S, Leongito M, Granata V, Barbieri A, Del Vecchio V, Falco M, Nasto A, Albino V, Piccirillo M, Palaia R, Amore A, Giacomo Rd, Lastoria S, Setola SV, Fusco R, ... ... Izzo F, et al. Electrochemotherapy in pancreatic adenocarcinoma treatment: pre-clinical and clinical studies. Radiology and Oncology. 50: 14-20. PMID 27069445 DOI: 10.1515/raon-2016-0003 |
0.192 |
|
2021 |
Avallone A, Piccirillo MC, Nasti G, Rosati G, Carlomagno C, Di Gennaro E, Romano C, Tatangelo F, Granata V, Cassata A, Silvestro L, De Stefano A, Aloj L, Vicario V, Nappi A, ... ... Izzo F, et al. Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial. Jama Network Open. 4: e2118475. PMID 34309665 DOI: 10.1001/jamanetworkopen.2021.18475 |
0.192 |
|
2018 |
Avallone A, Nasti G, Rosati G, Carlomagno C, Silvestro L, Cassata A, Romano C, Granata V, De Stefano A, Tafuto S, Bianco F, Vicario V, Bilancia D, Lastoria S, Petrillo A, ... Izzo F, et al. Update survival analysis from a multicenter, randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 36: 3562-3562. DOI: 10.1200/JCO.2018.36.15_SUPPL.3562 |
0.191 |
|
2016 |
Antonio A, Piccirillo M, Nasti G, Rosati G, Chiara C, Romano C, Bilancia D, De Stefano A, Ottaiano A, Cassata A, Bianco F, Delrio P, Izzo F, Di Gennaro E, Caracò C, et al. A multicentre, randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer (mCRC) Annals of Oncology. 27: iv42. DOI: 10.1093/ANNONC/MDW335.11 |
0.19 |
|
2018 |
Avallone A, Nasti G, Rosati G, Carlomagno C, Romano C, Bilancia D, De Stefano A, Silvestro L, Ottaiano A, Cassata A, Bianco F, Izzo F, Delrio P, De Gennaro E, Casaretti R, et al. Survival analysis of a multicentre, randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC). Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: v74. PMID 32177246 DOI: 10.1093/annonc/mdy151.262 |
0.19 |
|
2012 |
Turati F, Talamini R, Pelucchi C, Polesel J, Franceschi S, Crispo A, Izzo F, La Vecchia C, Boffetta P, Montella M. Metabolic syndrome and hepatocellular carcinoma risk. British Journal of Cancer. 108: 222-8. PMID 23169288 DOI: 10.1038/bjc.2012.492 |
0.19 |
|
2017 |
Petruzziello A, Marigliano S, Loquercio G, Coppola N, Piccirillo M, Leongito M, Azzaro R, Izzo F, Botti G. Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective study Infectious Agents and Cancer. 12. DOI: 10.1186/s13027-017-0162-5 |
0.19 |
|
2014 |
Pivonello C, De Martino MC, Negri M, Cuomo G, Cariati F, Izzo F, Colao A, Pivonello R. The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets. Infectious Agents and Cancer. 9: 27. PMID 25225571 DOI: 10.1186/1750-9378-9-27 |
0.189 |
|
2020 |
Granata V, Fusco R, Setola SV, Avallone A, Palaia R, Grassi R, Izzo F, Petrillo A. Radiological assessment of secondary biliary tree lesions: an update. The Journal of International Medical Research. 48: 300060519850398. PMID 32597280 DOI: 10.1177/0300060519850398 |
0.189 |
|
2016 |
Granata V, Fusco R, Catalano O, Guarino B, Granata F, Tatangelo F, Avallone A, Piccirillo M, Palaia R, Izzo F, Petrillo A. Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for Hepatocellular carcinoma: correlation with histologic grade. Oncotarget. PMID 27764817 DOI: 10.18632/oncotarget.12689 |
0.187 |
|
2010 |
Castello G, Scala S, Palmieri G, Curley SA, Izzo F. HCV-related hepatocellular carcinoma: From chronic inflammation to cancer. Clinical Immunology (Orlando, Fla.). 134: 237-50. PMID 19910258 DOI: 10.1016/j.clim.2009.10.007 |
0.185 |
|
2015 |
Granata V, Fusco R, Catalano O, Filice S, Amato DM, Nasti G, Avallone A, Izzo F, Petrillo A. Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging. Plos One. 10: e0142876. PMID 26566221 DOI: 10.1371/journal.pone.0142876 |
0.184 |
|
2005 |
Smith DL, Arens JF, Barnett CC, Izzo F, Curley SA. A prospective evaluation of ultrasound-directed transparenchymal vascular control with linear cutting staplers in major hepatic resections. American Journal of Surgery. 190: 23-9. PMID 15972166 DOI: 10.1016/j.amjsurg.2004.12.003 |
0.184 |
|
2022 |
Ottaiano A, Santorsola M, Circelli L, Cascella M, Petrillo N, Perri F, Casillo M, Granata V, Ianniello M, Izzo F, Picone C, Correra M, Petrillo A, Sirica R, Misso G, et al. Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection. Therapeutic Advances in Medical Oncology. 14: 17588359221138388. PMID 36518158 DOI: 10.1177/17588359221138388 |
0.183 |
|
2013 |
Lastoria S, Piccirillo MC, Caracò C, Nasti G, Aloj L, Arrichiello C, de Lutio di Castelguidone E, Tatangelo F, Ottaiano A, Iaffaioli RV, Izzo F, Romano G, Giordano P, Signoriello S, Gallo C, et al. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 2062-9. PMID 24136935 DOI: 10.2967/jnumed.113.119909 |
0.183 |
|
2023 |
Cioffi L, Belli G, Izzo F, Fantini C, D'Agostino A, Russo G, Patrone R, Granata V, Belli A. Minimally Invasive ALPPS Procedure: A Review of Feasibility and Short-Term Outcomes. Cancers. 15. PMID 36980586 DOI: 10.3390/cancers15061700 |
0.182 |
|
2008 |
Cosimelli M, Mancini R, Carpanese L, Sciuto R, Sperduti I, Golfieri R, Giampalma E, Cagol P, Bacchetti S, Izzo F. Clinical safety and efficacy of 90yttrium resin microspheres alone in unresectable, heavily pre-treated colorectal liver metastases: results of a phase II trial Journal of Clinical Oncology. 26: 4078-4078. DOI: 10.1200/JCO.2008.26.15_SUPPL.4078 |
0.182 |
|
2017 |
Avallone A, Nasti G, Rosati G, Carlomagno C, Romano C, Bilancia D, De Stefano A, Ottaiano A, Cassata A, Silvestro L, Tafuto S, Bianco F, Delrio P, Izzo F, Di Gennaro E, et al. A multicentre, randomized phase 3 study on the optimization of the combination of bevacizumab with mFOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC) Annals of Oncology. 28: v173-v174. DOI: 10.1093/ANNONC/MDX393.040 |
0.182 |
|
2017 |
Avallone A, Nasti G, Rosati G, Carlomagno C, Romano C, Bilancia D, De Stefano A, Ottaiano A, Cassata A, Bianco F, Del Rio P, Izzo F, Silvestro L, Tafuto S, Di Gennaro E, et al. Optimization of the combination of bevacizumab with FOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC): the multicentre, randomized phase 3 study OBELICS Annals of Oncology. 28: vi5. DOI: 10.1093/annonc/mdx422.007 |
0.182 |
|
2007 |
Polesel J, Talamini R, Montella M, Maso LD, Crovatto M, Parpinel M, Izzo F, Tommasi LG, Serraino D, La Vecchia C, Franceschi S. Nutrients intake and the risk of hepatocellular carcinoma in Italy. European Journal of Cancer (Oxford, England : 1990). 43: 2381-7. PMID 17719221 DOI: 10.1016/j.ejca.2007.07.012 |
0.181 |
|
2023 |
Ottaiano A, Santorsola M, Circelli L, Trotta AM, Izzo F, Perri F, Cascella M, Sabbatino F, Granata V, Correra M, Tarotto L, Stilo S, Fiore F, Martucci N, Rocca A, et al. Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives. Cancers. 15. PMID 36980713 DOI: 10.3390/cancers15061827 |
0.181 |
|
2001 |
Izzo F, Thomas R, Delrio P, Rinaldo M, Vallone P, DeChiara A, Botti G, D'Aiuto G, Cortino P, Curley SA. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer. 92: 2036-44. PMID 11596017 DOI: 10.1002/1097-0142(20011015)92:8<2036::AID-CNCR1542>3.0.CO;2-W |
0.18 |
|
2006 |
Comella P, Massidda B, Palmeri S, Putzu C, De Rosa V, Izzo F, Fiore F, Casaretti R, Sandomenico C. Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer. Anti-Cancer Drugs. 17: 985-92. PMID 16940809 DOI: 10.1097/01.cad.0000224452.62071.ce |
0.18 |
|
2010 |
Paris D, Melck D, Stocchero M, D’Apolito O, Calemma R, Castello G, Izzo F, Palmieri G, Corso G, Motta A. Monitoring liver alterations during hepatic tumorigenesis by NMR profiling and pattern recognition Metabolomics. 6: 405-416. DOI: 10.1007/s11306-010-0209-8 |
0.178 |
|
1996 |
Izzo F, Curley S, Maio P, Leonardi E, Imparato L, Giglio S, Cremona F, Castello G. Correlation of soluble interleukin-2 receptor levels with severity of chronic hepatitis C virus liver injury and development of hepatocellular cancer. Surgery. 120: 100-5. PMID 8693411 DOI: 10.1016/S0039-6060(96)80247-9 |
0.177 |
|
2021 |
Granata V, Fusco R, D'Alessio V, Giannini A, Venanzio Setola S, Belli A, Palaia R, Petrillo A, Izzo F. Electroporation-based treatments in minimally invasive percutaneous, laparoscopy and endoscopy procedures for treatment of deep-seated tumors. European Review For Medical and Pharmacological Sciences. 25: 3536-3545. PMID 34002828 DOI: 10.26355/eurrev_202105_25836 |
0.177 |
|
2022 |
Granata V, Fusco R, De Muzio F, Cutolo C, Mattace Raso M, Gabelloni M, Avallone A, Ottaiano A, Tatangelo F, Brunese MC, Miele V, Izzo F, Petrillo A. Radiomics and Machine Learning Analysis Based on Magnetic Resonance Imaging in the Assessment of Colorectal Liver Metastases Growth Pattern. Diagnostics (Basel, Switzerland). 12. PMID 35626271 DOI: 10.3390/diagnostics12051115 |
0.177 |
|
2013 |
Piccirillo MC, Lastoria S, Nasti G, Caraco C, Aloj L, Arrichiello C, Ottaiano A, Izzo F, De Lutio E, Albino V, Romano C, Palaia R, Daniele G, Di Maio M, Giordano P, et al. Early PET/CT scan compared with RECIST to predict long-term outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab. Journal of Clinical Oncology. 31: 11008-11008. DOI: 10.1200/JCO.2013.31.15_SUPPL.11008 |
0.176 |
|
2023 |
Cotsoglou C, Granieri S, Bassetto S, Bagnardi V, Pugliese R, Grazi GL, Guglielmi A, Ruzzenente A, Aldrighetti L, Ratti F, De Carlis L, De Carlis R, Centonze L, De Angelis N, Memeo R, ... ... Izzo F, et al. Dynamic surgical anatomy using 3D reconstruction technology in complex hepato-biliary surgery with vascular involvement. Results from an international multicentric survey. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. PMID 37838501 DOI: 10.1016/j.hpb.2023.10.003 |
0.175 |
|
2013 |
Buonaguro FM, Tornesello M, Izzo F, De Giorgi V, Worschech A, Wang E, Marincola F, Buonaguro L. G104 Molecular Signatures in Human Liver Cancer Jaids Journal of Acquired Immune Deficiency Syndromes. 62: 59. DOI: 10.1097/01.qai.0000429257.85522.75 |
0.174 |
|
2016 |
De Re V, De Zorzi M, Caggiari L, Lauletta G, Tornesello ML, Fognani E, Miorin M, Racanelli V, Quartuccio L, Gragnani L, Russi S, Pavone F, Ghersetti M, Costa EG, Casarin P, ... ... Izzo F, et al. HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2. Oncotarget. PMID 27183918 DOI: 10.18632/oncotarget.9303 |
0.173 |
|
2015 |
Granata V, Fusco R, Piccirillo M, Palaia R, Petrillo A, Lastoria S, Izzo F. Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results. International Journal of Surgery (London, England). 18: 230-6. PMID 25917204 DOI: 10.1016/j.ijsu.2015.04.055 |
0.172 |
|
2012 |
Lencioni R, Izzo F, Crocetti L, Vilgrain V, Abdel-Rehim M, Bianchi L, Ricke J, Pech M, Bruix J. Abstract No LB12: A prospective, multicenter phase II clinical trial using irreversible electroporation for the treatment of early stage HCC Journal of Vascular and Interventional Radiology. 23: 1114. DOI: 10.1016/J.JVIR.2012.05.018 |
0.172 |
|
2019 |
Belli A, Gallo M, Piccirillo M, Izzo F. Bone metastases as initial presentation of hepatocellular carcinoma. The Lancet. Oncology. 20: e549. PMID 31486371 DOI: 10.1016/S1470-2045(19)30417-6 |
0.171 |
|
2016 |
Pivonello C, Negri M, De Martino MC, Napolitano M, de Angelis C, Provvisiero DP, Cuomo G, Auriemma RS, Simeoli C, Izzo F, Colao A, Hofland LJ, Pivonello R. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma. Oncotarget. 7: 9718-31. PMID 26756219 DOI: 10.18632/oncotarget.6836 |
0.171 |
|
2021 |
Ottaiano A, Scala S, Santorsola M, Trotta AM, D'Alterio C, Portella L, Clemente O, Nappi A, Zanaletti N, De Stefano A, Avallone A, Granata V, Notariello C, Luce A, Lombardi A, ... ... Izzo F, et al. Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol. Therapeutic Advances in Medical Oncology. 13: 1758835921989223. PMID 33854566 DOI: 10.1177/1758835921989223 |
0.171 |
|
2012 |
Nasti G, Ottaiano A, Romano C, Izzo F, Delrio P, Albino V, Giordano P, Piccirillo MC, Daniele G, Lastoria S, Caraco C, Arrichiello C, De Lutio E, Maiolino P, Tatangelo F, et al. FOLFIRI plus bevacizumab (B) as neoadjuvant treatment for potentially resectable colorectal cancer patients (pts) with liver metastasis: A phase II trial. Journal of Clinical Oncology. 30: e14130-e14130. DOI: 10.1200/JCO.2012.30.15_SUPPL.E14130 |
0.17 |
|
2023 |
Granata V, Fusco R, Setola SV, Simonetti I, Picone C, Simeone E, Festino L, Vanella V, Vitale MG, Montanino A, Morabito A, Izzo F, Ascierto PA, Petrillo A. Immunotherapy Assessment: A New Paradigm for Radiologists. Diagnostics (Basel, Switzerland). 13. PMID 36673112 DOI: 10.3390/diagnostics13020302 |
0.17 |
|
2007 |
Izzo F, Montella M, Orlando AP, Nasti G, Beneduce G, Castello G, Cremona F, Ensor CM, Holtzberg FW, Bomalaski JS, Clark MA, Curley SA, Orlando R, Scordino F, Korba BE. Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesis. Journal of Gastroenterology and Hepatology. 22: 86-91. PMID 17201887 DOI: 10.1111/J.1440-1746.2006.04463.X |
0.169 |
|
1996 |
Guida C, Scoppa G, Russo Spena F, Elmo M, Palaia R, Izzo F, Ruffolo F, Cremona F, Parisi V. 620Concurrent accelerated radiotherapy and continuous infusion chemotherapy in the neoadiuvant treatment of rectal cancer: A pilot study Radiotherapy and Oncology. 40: S158. DOI: 10.1016/S0167-8140(96)80629-3 |
0.169 |
|
2009 |
De Giorgi V, Monaco A, Worchech A, Tornesello M, Izzo F, Buonaguro L, Marincola FM, Wang E, Buonaguro FM. Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma. Journal of Translational Medicine. 7: 85. PMID 19821982 DOI: 10.1186/1479-5876-7-85 |
0.168 |
|
2022 |
Granata V, Simonetti I, Fusco R, Setola SV, Izzo F, Scarpato L, Vanella V, Festino L, Simeone E, Ascierto PA, Petrillo A. Management of cutaneous melanoma: radiologists challenging and risk assessment. La Radiologia Medica. 127: 899-911. PMID 35834109 DOI: 10.1007/s11547-022-01522-4 |
0.167 |
|
2019 |
Granata V, Fusco R, Filice S, Incollingo P, Belli A, Izzo F, Petrillo A. Comment on "State of the art in magnetic resonance imaging of hepatocellular carcinoma": the role of DWI. Radiology and Oncology. PMID 31318697 DOI: 10.2478/raon-2019-0031 |
0.166 |
|
2022 |
Patrone R, Leongito M, di Giacomo R, Belli A, Palaia R, Amore A, Albino V, Piccirillo M, Cutolo C, Coluccia S, Nasto A, Conzo G, Crispo A, Granata V, Izzo F. Is There Indication for the Use of Biological Mesh in Cancer Patients? Journal of Clinical Medicine. 11. PMID 36294356 DOI: 10.3390/jcm11206035 |
0.166 |
|
2011 |
Montella M, Polesel J, Talamini R, Crispo A, Giudice A, Izzo F, La Vecchia C. Metabolic syndrome is also a risk factor for primary liver cancer in patients younger than 65 years of age? Hepatology (Baltimore, Md.). 54: 2277-8. PMID 21898495 DOI: 10.1002/hep.24643 |
0.166 |
|
2021 |
Granata V, Fusco R, Izzo F, Venanzio Setola S, Coppola M, Grassi R, Reginelli A, Cappabianca S, Grassi R, Petrillo A. Covid-19 infection in cancer patients: the management in a diagnostic unit. Radiology and Oncology. PMID 33675200 DOI: 10.2478/raon-2021-0010 |
0.165 |
|
2021 |
Granata V, Grassi R, Fusco R, Belli A, Palaia R, Carrafiello G, Miele V, Grassi R, Petrillo A, Izzo F. Local ablation of pancreatic tumors: State of the art and future perspectives. World Journal of Gastroenterology. 27: 3413-3428. PMID 34163121 DOI: 10.3748/wjg.v27.i23.3413 |
0.164 |
|
2004 |
Izzo F. Mark Everist, Music Drama at the Paris Odéon, 1824–1828 (Berkeley, Los Angeles, and London: University of California Press, 2002). xvii + 331pp. £40. Music examples, illustrations, bibliography, index Nineteenth-Century Music Review. 1: 102-104. DOI: 10.1017/S1479409800001385 |
0.161 |
|
2019 |
Belli A, Palaia R, Albino V, Amore A, Piccirillo M, Leongito M, Nasti G, Granata V, Petrillo A, Lastoria S, Izzo F. Neoadjuvant Folfiri+Bevacizumab in resectable liver metastases from CRC: results and comparison of PET/CT scan vs RECIST in predicting outcome Hpb. 21: S621-S622. DOI: 10.1016/j.hpb.2019.10.324 |
0.161 |
|
2023 |
De Muzio F, Pellegrino F, Fusco R, Tafuto S, Scaglione M, Ottaiano A, Petrillo A, Izzo F, Granata V. Prognostic Assessment of Gastropancreatic Neuroendocrine Neoplasm: Prospects and Limits of Radiomics. Diagnostics (Basel, Switzerland). 13. PMID 37761243 DOI: 10.3390/diagnostics13182877 |
0.161 |
|
2022 |
Simonetti I, Bruno F, Fusco R, Cutolo C, Setola SV, Patrone R, Masciocchi C, Palumbo P, Arrigoni F, Picone C, Belli A, Grassi R, Grassi F, Barile A, Izzo F, et al. Multimodality Imaging Assessment of Desmoid Tumors: The Great Mime in the Era of Multidisciplinary Teams. Journal of Personalized Medicine. 12. PMID 35887650 DOI: 10.3390/jpm12071153 |
0.161 |
|
2017 |
Reginelli A, Granata V, Fusco R, Granata F, Rega D, Roberto L, Pellino G, Rotondo A, Selvaggi F, Izzo F, Petrillo A, Grassi R. Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer. Oncotarget. PMID 28152518 DOI: 10.18632/oncotarget.14946 |
0.16 |
|
2014 |
Izzo F, Albino V, Palaia R, Piccirillo M, Tatangelo F, Granata V, Petrillo A, Lastoria S. Hepatocellular carcinoma: preclinical data on a dual-lumen catheter kit for fibrin sealant infusion following loco-regional treatments. Infectious Agents and Cancer. 9: 39. PMID 25489337 DOI: 10.1186/1750-9378-9-39 |
0.159 |
|
2023 |
Lorenzon L, Caccialanza R, Casalone V, Santoro G, Delrio P, Izzo F, Tonello M, Mele MC, Pozzo C, Pedrazzoli P, Pietrabissa A, Fenu P, Mellano A, Fenocchio E, Avallone A, et al. The impact of preoperative nutritional screening, ERAS protocol, and mini-invasive surgery in surgical oncology: A multi-institutional SEM analysis of patients with digestive cancer. Frontiers in Nutrition. 10: 1041153. PMID 37006925 DOI: 10.3389/fnut.2023.1041153 |
0.159 |
|
2021 |
Izzo F, Granata V, Fusco R, D'Alessio V, Petrillo A, Lastoria S, Piccirillo M, Albino V, Belli A, Tafuto S, Avallone A, Patrone R, Palaia R. Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy. Journal of Clinical Medicine. 10. PMID 33810058 DOI: 10.3390/jcm10061305 |
0.158 |
|
2022 |
Granata V, Palaia R, Izzo F. Comments on "The beneficial role of electrochemotherapy in locally advanced pancreatic cancer - radiological perspective". Polish Journal of Radiology. 87: e668-e669. PMID 36643010 DOI: 10.5114/pjr.2022.123567 |
0.155 |
|
2022 |
Granata V, Fusco R, Setola SV, Simonetti I, Cozzi D, Grazzini G, Grassi F, Belli A, Miele V, Izzo F, Petrillo A. An update on radiomics techniques in primary liver cancers. Infectious Agents and Cancer. 17: 6. PMID 35246207 DOI: 10.1186/s13027-022-00422-6 |
0.153 |
|
2020 |
Buonaguro FM, Botti G, Ascierto PA, Pignata S, Ionna F, Delrio P, Petrillo A, Cavalcanti E, Di Bonito M, Perdonà S, De Laurentiis M, Fiore F, Palaia R, Izzo F, D'Auria S, et al. The clinical and translational research activities at the INT - IRCCS "Fondazione Pascale" cancer center (Naples, Italy) during the COVID-19 pandemic. Infectious Agents and Cancer. 15: 69. PMID 33292365 DOI: 10.1186/s13027-020-00330-7 |
0.153 |
|
2022 |
Granata V, Palaia R, Izzo F. Commentary: The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer. Frontiers in Oncology. 12: 955444. PMID 36185275 DOI: 10.3389/fonc.2022.955444 |
0.153 |
|
2000 |
Montella M, Crispo A, Pezzullo L, Izzo F, Fabbrocini G, Ronga D, Tamburini M. Is hepatitis C virus infection associated with thyroid cancer? A case-control study. International Journal of Cancer. 87: 611-2. PMID 10918206 DOI: 10.1002/1097-0215(20000815)87:4<611::AID-IJC24>3.0.CO;2-N |
0.151 |
|
2021 |
Granata V, Fusco R, Barretta ML, Picone C, Avallone A, Belli A, Patrone R, Ferrante M, Cozzi D, Grassi R, Grassi R, Izzo F, Petrillo A. Radiomics in hepatic metastasis by colorectal cancer. Infectious Agents and Cancer. 16: 39. PMID 34078424 DOI: 10.1186/s13027-021-00379-y |
0.151 |
|
2018 |
Izzo F. Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results Archives in Cancer Research. 6. DOI: 10.21767/2254-6081-C3-011 |
0.151 |
|
2021 |
Granata V, Grassi R, Fusco R, Setola SV, Belli A, Ottaiano A, Nasti G, La Porta M, Danti G, Cappabianca S, Cutolo C, Petrillo A, Izzo F. Intrahepatic cholangiocarcinoma and its differential diagnosis at MRI: how radiologist should assess MR features. La Radiologia Medica. 126: 1584-1600. PMID 34843029 DOI: 10.1007/s11547-021-01428-7 |
0.15 |
|
1995 |
Davidson BS, Izzo F, Cromeens DM, Stephens LC, Siddik ZH, Curley SA. Collagen matrix cisplatin prevents local tumor growth after margin-positive resection. The Journal of Surgical Research. 58: 618-24. PMID 7791337 DOI: 10.1006/jsre.1995.1097 |
0.149 |
|
2006 |
Palmieri G, Colombino M, Camboni MG, Manca A, Baldinu P, Izzo F, Tatangelo F, Calemma R, Cossu A, Galimi F. Assessment of the role of Fanconi Anemia (FA) genes in colorectal cancer: A new pathogenetic pathway? Journal of Clinical Oncology. 24: 3629-3629. DOI: 10.1200/jco.2006.24.18_suppl.3629 |
0.148 |
|
2023 |
Ottaiano A, Santorsola M, Capuozzo M, Perri F, Circelli L, Cascella M, Ianniello M, Sabbatino F, Granata V, Izzo F, Iervolino D, Casillo M, Petrillo N, Gualillo O, Nasti G, et al. The prognostic role of p53 mutations in metastatic colorectal cancer: a systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 104018. PMID 37150312 DOI: 10.1016/j.critrevonc.2023.104018 |
0.148 |
|
2023 |
Ottaiano A, De Luca A, Santorsola M, Scognamiglio G, Di Mauro A, Chiodini P, Lambiase M, Sacco A, Petrillo A, Granata V, Fusco R, Mercadante E, Martucci N, De Luca G, Rocca A, ... ... Izzo F, et al. Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study. Bmc Cancer. 23: 1010. PMID 37858132 DOI: 10.1186/s12885-023-11479-w |
0.147 |
|
2011 |
Colombino M, Avallone A, Izzo F, Tatangelo F, Budroni M, Cossu A, Galimi F, Comella P, Botti G, Sini MC, Tanda F, Palmieri G. Molecular analysis of Fanconi anemia and mismatch repair genes in patients with colorectal carcinoma. Oncology Reports. 25: 899-904. PMID 21286667 DOI: 10.3892/or.2011.1169 |
0.146 |
|
2017 |
Mayer A, Accolla R, Ma Y, Heidenreich R, Koenigsrainer A, Izzo F, Loeffler M, Flohr C, Mueller P, Kutscher S, Rammensee H, Sangro B, Francque S, Valmori D, Weinschenk T, et al. Discovery to first-in-man studies of a multi-peptide-based hepatocellular carcinoma vaccine adjuvanted with CV8102 (RNAdjuvant) – HEPAVAC Journal of Hepatology. 66: S445-S446. DOI: 10.1016/S0168-8278(17)31266-7 |
0.145 |
|
2019 |
Granata V, Fusco R, Setola SV, Castelguidone ELD, Camera L, Tafuto S, Avallone A, Belli A, Incollingo P, Palaia R, Izzo F, Petrillo A. The multidisciplinary team for gastroenteropancreatic neuroendocrine tumours: the radiologist's challenge. Radiology and Oncology. PMID 31652122 DOI: 10.2478/raon-2019-0040 |
0.145 |
|
2021 |
Granata V, Grassi R, Fusco R, Galdiero R, Setola SV, Palaia R, Belli A, Silvestro L, Cozzi D, Brunese L, Petrillo A, Izzo F. Pancreatic cancer detection and characterization: state of the art and radiomics. European Review For Medical and Pharmacological Sciences. 25: 3684-3699. PMID 34109578 DOI: 10.26355/eurrev_202105_25935 |
0.145 |
|
2016 |
Bimonte S, Barbieri A, Leongito M, Palma G, Del Vecchio V, Falco M, Palaia R, Albino V, Piccirillo M, Amore A, Petrillo A, Granata V, Izzo F. The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells. Stem Cells International. 2016: 8352684. PMID 27006664 DOI: 10.1155/2016/8352684 |
0.143 |
|
2020 |
Amato B, Patrone R, Quarto G, Compagna R, Cirocchi R, Popivanov G, Granata V, Belli A, Izzo F. Surgical treatment for common hepatic aneurysm. Original one-step technique. Open Medicine (Warsaw, Poland). 15: 898-904. PMID 33336047 DOI: 10.1515/med-2020-0104 |
0.143 |
|
2003 |
De Chiara A, Izzo F, Apice G, Ninfo V. Pathologic quiz case: two well-circumscribed masses in the liver. Archives of Pathology & Laboratory Medicine. 127: e255-6. PMID 12708927 DOI: 10.1043/0003-9985(2003)1272.0.CO;2 |
0.143 |
|
2015 |
Bimonte S, Leongito M, Barbieri A, Del Vecchio V, Barbieri M, Albino V, Piccirillo M, Amore A, Di Giacomo R, Nasto A, Granata V, Petrillo A, Arra C, Izzo F. Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth. Infectious Agents and Cancer. 10: 22. PMID 26225138 DOI: 10.1186/s13027-015-0016-y |
0.143 |
|
2003 |
Montella M, Pezzullo L, Crispo A, Izzo F, Amore A, Marone U, Tamburini M, Ronga D, Chiofalo MG, Chiappetta G, Mozzillo N. Risk of thyroid cancer and high prevalence of hepatitis C virus. Oncology Reports. 10: 133-6. PMID 12469158 |
0.141 |
|
2014 |
De Re V, Gragnani L, Fognani E, Piluso A, Izzo F, Mangia A, Crovatto M, Gava G, Casarin P, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Caggiari L, De Zorzi M, et al. Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection. Biomed Research International. 2014: 710642. PMID 24707497 DOI: 10.1155/2014/710642 |
0.14 |
|
2019 |
Granata V, Fusco R, Setola SV, Palaia R, Albino V, Piccirillo M, Grimm R, Petrillo A, Izzo F. Diffusion kurtosis imaging and conventional diffusion weighted imaging to assess electrochemotherapy response in locally advanced pancreatic cancer. Radiology and Oncology. PMID 30681974 DOI: 10.2478/raon-2019-0004 |
0.14 |
|
2020 |
De Luca A, Esposito Abate R, Rachiglio AM, Maiello MR, Esposito C, Schettino C, Izzo F, Nasti G, Normanno N. FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention. International Journal of Molecular Sciences. 21. PMID 32962091 DOI: 10.3390/ijms21186856 |
0.139 |
|
2011 |
Di Vuolo V, Buonaguro L, Izzo F, Losito S, Botti G, Buonaguro FM, Tornesello ML. TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients. Infectious Agents and Cancer. 6: 13. PMID 21843334 DOI: 10.1186/1750-9378-6-13 |
0.139 |
|
2021 |
Granata V, Fusco R, Avallone A, De Stefano A, Ottaiano A, Sbordone C, Brunese L, Izzo F, Petrillo A. Radiomics-Derived Data by Contrast Enhanced Magnetic Resonance in RAS Mutations Detection in Colorectal Liver Metastases. Cancers. 13. PMID 33504085 DOI: 10.3390/cancers13030453 |
0.138 |
|
2011 |
Manca A, Sini MC, Izzo F, Ascierto PA, Tatangelo F, Botti G, Gentilcore G, Capone M, Mozzillo N, Rozzo C, Cossu A, Tanda F, Palmieri G. Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells. Oncology Reports. 25: 1495-502. PMID 21424129 DOI: 10.3892/or.2011.1220 |
0.138 |
|
2016 |
D'Alterio C, Nasti G, Polimeno M, Ottaiano A, Conson M, Circelli L, Botti G, Scognamiglio G, Santagata S, De Divitiis C, Nappi A, Napolitano M, Tatangelo F, Pacelli R, Izzo F, et al. CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients. Oncoimmunology. 5: e1254313. PMID 28123896 DOI: 10.1080/2162402X.2016.1254313 |
0.138 |
|
1993 |
Izzo F, Cremona F, Ruffolo F, Palaia R, Parisi V, Napolitano M, Lacagnina A. Manipulation of the perioperative immunologic state in patients with colorectal tumors European Journal of Cancer. 29: S100. DOI: 10.1016/0959-8049(93)91157-G |
0.137 |
|
2016 |
Bimonte S, Leongito M, Piccirillo M, Tamma ML, Vallifuoco M, Bracco A, Mancini A, Di Napoli D, Castaldo S, Cozzolino S, Iacobellis F, Grassi R, Granata V, Lastoria S, Curley S, ... Izzo F, et al. Induction of VX2 para-renal carcinoma in rabbits: generation of animal model for loco-regional treatments of solid tumors. Infectious Agents and Cancer. 11: 62. PMID 27980609 DOI: 10.1186/s13027-016-0103-8 |
0.136 |
|
2023 |
Granata V, Fusco R, D'Alessio V, Simonetti I, Grassi F, Silvestro L, Palaia R, Belli A, Patrone R, Piccirillo M, Izzo F. Percutanous Electrochemotherapy (ECT) in Primary and Secondary Liver Malignancies: A Systematic Review. Diagnostics (Basel, Switzerland). 13. PMID 36673019 DOI: 10.3390/diagnostics13020209 |
0.134 |
|
2020 |
Granata V, Fusco R, Risi C, Ottaiano A, Avallone A, De Stefano A, Grimm R, Grassi R, Brunese L, Izzo F, Petrillo A. Diffusion-Weighted MRI and Diffusion Kurtosis Imaging to Detect RAS Mutation in Colorectal Liver Metastasis. Cancers. 12. PMID 32858990 DOI: 10.3390/cancers12092420 |
0.133 |
|
2015 |
Bimonte S, Barbieri A, Palma G, Rea D, Luciano A, D'Aiuto M, Arra C, Izzo F. Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer. Biomed Research International. 2015: 878134. PMID 25879038 DOI: 10.1155/2015/878134 |
0.132 |
|
2017 |
Granata V, Fusco R, Catalano O, Avallone A, Leongito M, Izzo F, Petrillo A. Peribiliary liver metastases MR findings. Medical Oncology (Northwood, London, England). 34: 124. PMID 28573638 DOI: 10.1007/s12032-017-0981-7 |
0.13 |
|
2017 |
Granata V, Fusco R, Catalano O, Avallone A, Palaia R, Botti G, Tatangelo F, Granata F, Cascella M, Izzo F, Petrillo A. Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases. Plos One. 12: e0179951. PMID 28632786 DOI: 10.1371/journal.pone.0179951 |
0.129 |
|
2020 |
von Arx C, Rea G, Napolitano M, Ottaiano A, Tatangelo F, Izzo F, Petrillo A, Clemente O, Di Sarno A, Botti G, Scala S, Tafuto S. Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study. Cancers. 12. PMID 32859050 DOI: 10.3390/cancers12092422 |
0.126 |
|
2015 |
Bimonte S, Barbieri A, Rea D, Palma G, Luciano A, Cuomo A, Arra C, Izzo F. Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression. Biomed Research International. 2015: 161508. PMID 26064880 DOI: 10.1155/2015/161508 |
0.123 |
|
2022 |
Ottaiano A, de Vera d'Aragona RP, Trotta AM, Santorsola M, Napolitano M, Scognamiglio G, Tatangelo F, Grieco P, Zappavigna S, Granata V, Perri F, Luce A, Savarese G, Ianniello M, Casillo M, ... ... Izzo F, et al. Characterization of KRAS Mutational Regression in Oligometastatic Patients. Frontiers in Immunology. 13: 898561. PMID 35936004 DOI: 10.3389/fimmu.2022.898561 |
0.122 |
|
2019 |
Ottaiano A, Scala S, Normanno N, Napolitano M, Capozzi M, Rachiglio AM, Roma C, Trotta AM, D'Alterio C, Portella L, Romano C, Cassata A, Casaretti R, Silvestro L, Nappi A, ... ... Izzo F, et al. Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol. Bmc Cancer. 19: 899. PMID 31500586 DOI: 10.1186/s12885-019-6109-z |
0.12 |
|
2024 |
Cavalluzzo B, Viuff MC, Tvingsholm SA, Ragone C, Manolio C, Mauriello A, Buonaguro FM, Tornesello ML, Izzo F, Morabito A, Hadrup SR, Tagliamonte M, Buonaguro L. Cross-reactive CD8 T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs). Journal of Experimental & Clinical Cancer Research : Cr. 43: 87. PMID 38509571 DOI: 10.1186/s13046-024-03004-z |
0.12 |
|
2024 |
Ottaiano A, Santorsola M, Diana A, Belli A, Lentini Graziano ML, Orefice J, Patrone R, Di Mauro A, Scognamiglio G, Tatangelo F, De Bellis M, Piccirillo M, Fiore F, Stilo S, Tarotto L, ... ... Izzo F, et al. Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real-world study. Cancer Medicine. 13: e6892. PMID 38457226 DOI: 10.1002/cam4.6892 |
0.12 |
|
2024 |
Granata V, Petrillo A, Setola SV, Izzo F, Fusco R. Optimal imaging before local therapy of colorectal liver metastases. The Lancet. Oncology. 25: e100. PMID 38423053 DOI: 10.1016/S1470-2045(24)00033-0 |
0.12 |
|
2024 |
Granata V, Fusco R, Brunese MC, Di Mauro A, Avallone A, Ottaiano A, Izzo F, Normanno N, Petrillo A. Machine learning-based radiomics analysis in predicting RAS mutational status using magnetic resonance imaging. La Radiologia Medica. 129: 420-428. PMID 38308061 DOI: 10.1007/s11547-024-01779-x |
0.12 |
|
2024 |
Fusco R, Granata V, Simonetti I, Setola SV, Iasevoli MAD, Tovecci F, Lamanna CMP, Izzo F, Pecori B, Petrillo A. An Informative Review of Radiomics Studies on Cancer Imaging: The Main Findings, Challenges and Limitations of the Methodologies. Current Oncology (Toronto, Ont.). 31: 403-424. PMID 38248112 DOI: 10.3390/curroncol31010027 |
0.12 |
|
2024 |
Granata V, Fusco R, Brunese MC, Ferrara G, Tatangelo F, Ottaiano A, Avallone A, Miele V, Normanno N, Izzo F, Petrillo A. Machine Learning and Radiomics Analysis for Tumor Budding Prediction in Colorectal Liver Metastases Magnetic Resonance Imaging Assessment. Diagnostics (Basel, Switzerland). 14. PMID 38248029 DOI: 10.3390/diagnostics14020152 |
0.12 |
|
2023 |
Marrone G, Di Lauro M, Izzo F, Cornali K, Masci C, Vita C, Occhiuto F, Di Daniele N, De Lorenzo A, Noce A. Possible Beneficial Effects of Hydrolyzable Tannins Deriving from L. in Internal Medicine. Nutrients. 16. PMID 38201875 DOI: 10.3390/nu16010045 |
0.12 |
|
2015 |
De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, et al. Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases. Plos One. 10: e0117420. PMID 25700262 DOI: 10.1371/journal.pone.0117420 |
0.119 |
|
2005 |
Montella M, Crispo A, Grimaldi M, Ruffolo P, Ronga D, Izzo F, Mastro AA. An assessment of hepatitis C virus infection among health-care workers of the National Cancer Institute of Naples, Southern Italy. European Journal of Public Health. 15: 467-9. PMID 16037074 DOI: 10.1093/eurpub/cki032 |
0.119 |
|
2003 |
Comella P, Casaretti R, De Rosa V, Avallone A, Izzo F, Fiore F, Lapenta L, Comella G. Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 13: 1874-81. PMID 12453855 DOI: 10.1093/ANNONC/MDF307 |
0.118 |
|
2023 |
Ottaiano A, Santorsola M, Circelli L, Ianniello M, Casillo M, Petrillo N, Sabbatino F, Cascella M, Perri F, Capuozzo M, Albino V, Granata V, Izzo F, Di Mauro A, Berretta M, et al. BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer. Neoplasia (New York, N.Y.). 44: 100930. PMID 37634281 DOI: 10.1016/j.neo.2023.100930 |
0.118 |
|
2020 |
Granata V, Fusco R, Sansone M, Grassi R, Maio F, Palaia R, Tatangelo F, Botti G, Grimm R, Curley S, Avallone A, Izzo F, Petrillo A. Magnetic resonance imaging in the assessment of pancreatic cancer with quantitative parameter extraction by means of dynamic contrast-enhanced magnetic resonance imaging, diffusion kurtosis imaging and intravoxel incoherent motion diffusion-weighted imaging. Therapeutic Advances in Gastroenterology. 13: 1756284819885052. PMID 32499833 DOI: 10.1177/1756284819885052 |
0.112 |
|
2015 |
Circelli L, Ramundo V, Marotta V, Sciammarella C, Marciello F, Del Prete M, Sabatino L, Pasquali D, Izzo F, Scala S, Colao A, Faggiano A, Colantuoni V. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1. Journal of Cellular and Molecular Medicine. 19: 1735-41. PMID 25824098 DOI: 10.1111/jcmm.12552 |
0.111 |
|
2020 |
Izzo F, Ionna F, Granata V, Albino V, Patrone R, Longo F, Guida A, Delrio P, Rega D, Scala D, Pezzuto R, Fusco R, Di Bernardo E, D'Alessio V, Grassi R, et al. New Deployable Expandable Electrodes in the Electroporation Treatment in a Pig Model: A Feasibility and Usability Preliminary Study. Cancers. 12. PMID 32102182 DOI: 10.3390/cancers12020515 |
0.108 |
|
1998 |
Izzo F, Cremona F, Ruffolo F, Palaia R, Delrio P, Parisi V, Shumate C, Curley S. A novel double-stapled technique for subtotal gastrectomy and gastrojejunostomy: Results and complications in 73 patients Gastroenterology. 114: A1396. DOI: 10.1016/S0016-5085(98)85675-8 |
0.107 |
|
2001 |
Izzo F, Delrio P, Marra P, Cremono F, Parisi V, Barnett CC, Wang TN, Curley SA. Effective intraoperative hemostasis using a novel gelatin matrix: Report from 82 cancer surgery cases Gastroenterology. 120: A481. DOI: 10.1016/S0016-5085(08)82385-2 |
0.105 |
|
2006 |
de Bellis M, Rossi G, Marone P, Finale S, Fiore F, Delrio P, Izzo F, Voltura C, Nasti G, Casaretti R, Petrulio F, Tempesta A. Expandable metal stents for palliation of malignant colorectal obstruction. Report of 20 consecutive patients Digestive and Liver Disease. 38: S208. DOI: 10.1016/S1590-8658(06)80566-9 |
0.103 |
|
2015 |
De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, et al. Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases. Plos One. 10: e0128849. PMID 25978365 DOI: 10.1371/journal.pone.0128849 |
0.103 |
|
2022 |
Granata V, Fusco R, Vallone P, Setola SV, Picone C, Grassi F, Patrone R, Belli A, Izzo F, Petrillo A. Not only lymphadenopathy: case of chest lymphangitis assessed with MRI after COVID 19 vaccine. Infectious Agents and Cancer. 17: 8. PMID 35300727 DOI: 10.1186/s13027-022-00419-1 |
0.102 |
|
2020 |
Izzo F, Palaia R, Albino V, Piccirillo M, Belli A, Patrone R, Fusco R, Lastoria S, Granata V. Electrochemotherapy in Advanced Pancreatic Adenocarcinoma European Journal of Surgical Oncology. 46: e126. DOI: 10.1016/j.ejso.2019.11.326 |
0.102 |
|
2019 |
Belli A, Leongito M, Palaia R, Albino V, Amore A, Piccirillo M, Tafuto S, Setola S, Granata V, Petrillo A, Lastoria S, Izzo F. Electrochemotherapy in advanced pancreatic adenocarcinoma Hpb. 21: S692. DOI: 10.1016/j.hpb.2019.10.541 |
0.102 |
|
2014 |
Izzo F, Palaia R, Albino V, Di Giacomo R, Amore A, Saponara R, Leongito M, Setola S, Granata V, Petrillo A. 28. Electrochemotherapy in advanced pancreatic adenocarcinoma European Journal of Surgical Oncology (Ejso). 40: S20. DOI: 10.1016/J.EJSO.2014.08.025 |
0.102 |
|
2004 |
Montella M, Crispo A, Wynn-Bellezza J, Izzo F, Grimaldi M, Ronga D. The rising health and economic burden of chronic hepatitis C. Journal of Hepatology. 41: 353-4; author reply . PMID 15288490 DOI: 10.1016/j.jhep.2004.03.030 |
0.1 |
|
2005 |
Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A, Beneduce G, De Rosa V, Izzo F, Melucci MT, Ensor CM, Prestayko AW, Holtsberg FW, Bomalaski JS, Clark MA, et al. Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7660-8. PMID 16234528 DOI: 10.1200/JCO.2005.02.0933 |
0.099 |
|
2022 |
Granata V, Fusco R, Belli A, Danti G, Bicci E, Cutolo C, Petrillo A, Izzo F. Diffusion weighted imaging and diffusion kurtosis imaging in abdominal oncological setting: why and when. Infectious Agents and Cancer. 17: 25. PMID 35681237 DOI: 10.1186/s13027-022-00441-3 |
0.099 |
|
2000 |
Curley SA, Izzo F. Laparoscopic radiofrequency. Annals of Surgical Oncology. 7: 78-9. PMID 10761782 DOI: 10.1007/s10434-000-0078-x |
0.098 |
|
2020 |
Alberghina MF, Germinario C, Bartolozzi G, Bracci S, Grifa C, Izzo F, La Russa MF, Magrini D, Massa E, Mercurio M, Nardo VM, Oddo ME, Pagnotta SM, Pelagotti A, Ponterio RC, et al. The Tomb of the Diver and the frescoed tombs in Paestum (southern Italy): New insights from a comparative archaeometric study. Plos One. 15: e0232375. PMID 32330186 DOI: 10.1371/journal.pone.0232375 |
0.097 |
|
2016 |
Leongito M, Palaia R, Albino V, Di Giacomo R, Amore A, Piccirillo M, Tafuto S, Granata V, Petrillo A, Lastoria S, Izzo F. Electrochemotherapy with bleomycin in locally advanced pancreatic adenocarcinoma European Journal of Surgical Oncology (Ejso). 42: S213. DOI: 10.1016/j.ejso.2016.04.042 |
0.095 |
|
2022 |
Granata V, Fusco R, Belli A, Borzillo V, Palumbo P, Bruno F, Grassi R, Ottaiano A, Nasti G, Pilone V, Petrillo A, Izzo F. Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma. Infectious Agents and Cancer. 17: 13. PMID 35346300 DOI: 10.1186/s13027-022-00429-z |
0.094 |
|
2020 |
Granata V, Fusco R, Palaia R, Belli A, Petrillo A, Izzo F. Comments on "Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma". Annals of Surgical Oncology. PMID 33011913 DOI: 10.1245/s10434-020-09183-1 |
0.09 |
|
1999 |
Palaia R, Cremona F, Delrio P, Izzo F, Ruffolo F, Parisi V. Sentinel node biopsy in gastric cancer. Journal of Chemotherapy (Florence, Italy). 11: 230-1. PMID 10435690 DOI: 10.1179/JOC.1999.11.3.230 |
0.09 |
|
2001 |
Montella M, Crispo A, de Bellis G, Izzo F, Frigeri F, Ronga D, Spada O, Mettivier V, Tamburini M, Cuomo O. HCV and cancer: a case-control study in a high-endemic area. Liver. 21: 335-41. PMID 11589770 DOI: 10.1034/J.1600-0676.2001.210506.X |
0.086 |
|
2021 |
Granata V, Coppola F, Grassi R, Fusco R, Tafuto S, Izzo F, Reginelli A, Maggialetti N, Buccicardi D, Frittoli B, Rengo M, Bortolotto C, Prost R, Lacasella GV, Montella M, et al. Structured Reporting of Computed Tomography in the Staging of Neuroendocrine Neoplasms: A Delphi Consensus Proposal. Frontiers in Endocrinology. 12: 748944. PMID 34917023 DOI: 10.3389/fendo.2021.748944 |
0.085 |
|
2018 |
Mercurio M, Rossi M, Izzo F, Cappelletti P, Germinario C, Grifa C, Petrelli M, Vergara A, Langella A. The characterization of natural gemstones using non-invasive FT-IR spectroscopy: New data on tourmalines. Talanta. 178: 147-159. PMID 29136805 DOI: 10.1016/j.talanta.2017.09.030 |
0.085 |
|
2015 |
Gentile I, Scarano F, Celotti A, DE Iuliis E, Scarano R, Granata V, Pinchera B, Meola M, D'Ambra A, Piccirillo M, DI Paola F, Cavalcanti E, Izzo F, Scarpato N, Borgia G. Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection. In Vivo (Athens, Greece). 29: 399-404. PMID 25977388 |
0.085 |
|
2011 |
Menegozzo S, Comba P, Ferrante D, De Santis M, Gorini G, Izzo F, Magnani C, Pirastu R, Simonetti A, Tùnesi S, Menegozzo M. Mortality study in an asbestos cement factory in Naples, Italy. Annali Dell'Istituto Superiore Di Sanitã . 47: 296-304. PMID 21952156 DOI: DOI: 10.4415/ANN_11_03_10 |
0.082 |
|
2021 |
Marano M, Jain D, Aggarwal HK, Izzo F. Evaluation of Expected Ventilatory Response to Metabolic Acidosis in Severely Ill Patients. The Journal of the Association of Physicians of India. 69: 11-12. PMID 34781612 |
0.082 |
|
2015 |
Marano M, D'Amato A, Tomasino G, Izzo F, Capasso M, Auletta E. Prevalence and determinants of interatrial block in hemodialysis patients. International Urology and Nephrology. 47: 571-2. PMID 25604146 DOI: 10.1007/s11255-015-0914-3 |
0.079 |
|
2021 |
Granata V, Fusco R, Setola SV, Galdiero R, Picone C, Izzo F, D'Aniello R, Miele V, Grassi R, Grassi R, Petrillo A. Lymphadenopathy after Covid-19 Vaccine: Preliminary Ultrasound Findings. Biology. 10. PMID 33799618 DOI: 10.3390/biology10030214 |
0.079 |
|
2020 |
Belli A, Patrone R, Albino V, Leongito M, Piccirillo M, Granata V, Pasta G, Palaia R, Izzo F. Robotic surgery of gallbladder cancer Mini-Invasive Surgery. 2020. DOI: 10.20517/2574-1225.2020.70 |
0.077 |
|
2012 |
Trojsi F, Sagnelli A, Cirillo G, Piccirillo G, Femiano C, Izzo F, Monsurrò MR, Tedeschi G. Amyotrophic lateral sclerosis and multiple sclerosis overlap: a case report. Case Reports in Medicine. 2012: 324685. PMID 23326272 DOI: 10.1155/2012/324685 |
0.075 |
|
2012 |
Trojsi F, Sagnelli A, Vanacore N, Piccirillo G, Daniele L, Izzo F, Laiola A, Di Costanzo A, Savettieri G, Monsurrò MR, Tedeschi G. Clinical features and lifestyle of patients with amyotrophic lateral sclerosis in Campania: brief overview of an Italian database. Annali Dell'Istituto Superiore Di Sanità. 48: 287-91. PMID 23007053 DOI: DOI: 10.4415/ANN_12_03_09 |
0.07 |
|
2022 |
Sarno G, Calabrese P, Schiavo L, Izzo F, Pilone V. What are risk factors for COVID-19 vaccine breakthrough infections in patients with previous history of bariatric surgery? Excli Journal. 21: 786-790. PMID 35949488 DOI: 10.17179/excli2022-4873 |
0.069 |
|
2022 |
Granata V, Fusco R, Belli A, Borzillo V, Palumbo P, Bruno F, Grassi R, Ottaiano A, Nasti G, Pilone V, Petrillo A, Izzo F. Correction: Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma. Infectious Agents and Cancer. 17: 22. PMID 35546240 DOI: 10.1186/s13027-022-00438-y |
0.068 |
|
2014 |
Marano M, Izzo F, Zamboli P. [Acute reversible carpal tunnel syndrome following arteriovenous fistula surgery]. Giornale Italiano Di Nefrologia : Organo Ufficiale Della Società Italiana Di Nefrologia. 31. PMID 25098461 DOI: gin/00194.6 |
0.065 |
|
2021 |
Fusco R, Grassi R, Granata V, Setola SV, Grassi F, Cozzi D, Pecori B, Izzo F, Petrillo A. Artificial Intelligence and COVID-19 Using Chest CT Scan and Chest X-ray Images: Machine Learning and Deep Learning Approaches for Diagnosis and Treatment. Journal of Personalized Medicine. 11. PMID 34683133 DOI: 10.3390/jpm11100993 |
0.063 |
|
2020 |
Belli A, Izzo F, Belli G. Clinical value and cost-effectiveness of minimally invasive distal pancreatectomy. Hepatobiliary Surgery and Nutrition. 9: 205-207. PMID 32355680 DOI: 10.21037/hbsn.2019.10.19 |
0.063 |
|
2016 |
Granata V, Cascella M, Fusco R, dell'Aprovitola N, Catalano O, Filice S, Schiavone V, Izzo F, Cuomo A, Petrillo A. Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations. Biomed Research International. 2016: 3918292. PMID 27652261 DOI: 10.1155/2016/3918292 |
0.06 |
|
2019 |
Izzo F, Mercurio M, de Gennaro B, Aprea P, Cappelletti P, Daković A, Germinario C, Grifa C, Smiljanic D, Langella A. Surface modified natural zeolites (SMNZs) as nanocomposite versatile materials for health and environment. Colloids and Surfaces. B, Biointerfaces. 182: 110380. PMID 31362155 DOI: 10.1016/j.colsurfb.2019.110380 |
0.059 |
|
2019 |
Rocco M, Tartaglia M, Izzo FP, Varricchio E, Arena S, Scaloni A, Marra M. Comparative proteomic analysis of durum wheat shoots from modern and ancient cultivars. Plant Physiology and Biochemistry : Ppb. 135: 253-262. PMID 30590259 DOI: 10.1016/j.plaphy.2018.12.010 |
0.058 |
|
2020 |
Merola G, Fusco R, Di Bernardo E, D'Alessio V, Izzo F, Granata V, Contartese D, Cadossi M, Audenino A, Perazzolo Gallo G. Design and Characterization of a Minimally Invasive Bipolar Electrode for Electroporation. Biology. 9. PMID 32967343 DOI: 10.3390/biology9090303 |
0.053 |
|
2020 |
Marano M, Izzo F. On the CO gain in on-line hemodiafiltration. Seminars in Dialysis. PMID 32776548 DOI: 10.1111/sdi.12911 |
0.051 |
|
2016 |
Circelli L, Sciammarella C, Guadagno E, Tafuto S, Del Basso de Caro M, Botti G, Pezzullo L, Aria M, Ramundo V, Tatangelo F, Simona Losito N, Ieranò C, D'Alterio C, Izzo F, Ciliberto G, et al. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR. Oncotarget. PMID 26934559 DOI: 10.18632/oncotarget.7738 |
0.051 |
|
2022 |
Prigioniero A, Zuzolo D, Niinemets Ü, Postiglione A, Mercurio M, Izzo F, Trifuoggi M, Toscanesi M, Scarano P, Tartaglia M, Sciarrillo R, Guarino C. Particulate matter and polycyclic aromatic hydrocarbon uptake in relation to leaf surface functional traits in Mediterranean evergreens: Potentials for air phytoremediation. Journal of Hazardous Materials. 435: 129029. PMID 35525010 DOI: 10.1016/j.jhazmat.2022.129029 |
0.045 |
|
2014 |
Piccirillo M, Albino V, Amore A, di Giacomo R, Leongito M, Rinaldi L, Saponara R, Palaia R, Izzo F. Percutaneous implant of Denver peritoneovenous shunt for treatment of refractory ascites Digestive and Liver Disease. 46: e139. DOI: 10.1016/J.DLD.2014.08.024 |
0.044 |
|
2017 |
Bimonte S, Cascella M, Leongito M, Palaia R, Caliendo D, Izzo F, Cuomo A. [Panoramica sui risultati degli studi pre-clinici sugli effetti dell'epigallocatechina gallato, la più abbondante catechina presente nel tè verde, nel trattamento del cancro al pancreas.] Recenti Progressi in Medicina. 108: 282-287. PMID 28631776 DOI: 10.1701/2715.27715 |
0.043 |
|
2021 |
Smiljanić D, Daković A, Obradović M, Ožegović M, Izzo F, Germinario C, de Gennaro B. Application of Surfactant Modified Natural Zeolites for the Removal of Salicylic Acid-A Contaminant of Emerging Concern. Materials (Basel, Switzerland). 14. PMID 34947322 DOI: 10.3390/ma14247728 |
0.043 |
|
2022 |
Forgione G, Izzo F, Mercurio M, Cicchella D, Dini L, Giancane G, Paolucci M. Microplastics pollution in freshwater fishes in the South of Italy: Characterization, distribution, and correlation with environmental pollutants. The Science of the Total Environment. 864: 161032. PMID 36549536 DOI: 10.1016/j.scitotenv.2022.161032 |
0.042 |
|
2021 |
Grifa C, Germinario C, De Bonis A, Cavassa L, Izzo F, Mercurio M, Langella A, Kakoulli I, Fischer C, Barra D, Aiello G, Soricelli G, Vyhnal CR, Morra V. Archaeometric data from the ceramic workshop in Pompeii (Southern Italy). Data in Brief. 34: 106706. PMID 33490328 DOI: 10.1016/j.dib.2020.106706 |
0.038 |
|
2013 |
Caggiari L, De Zorzi M, Izzo F, Tornesello ML, Buonaguro FM, De Re V. Identification and sequence analysis of a novel human leukocyte antigen allele B*51:141. Tissue Antigens. 81: 55-6. PMID 23216293 DOI: 10.1111/tan.12038 |
0.036 |
|
1994 |
Botti G, Gravina A, Cremona F, Izzo F, Rigutini M, Picone A. Subcutaneous sacrococcygeal myxopapillary ependymoma. A case report. European Journal of Cancer (Oxford, England : 1990). 30: 570-1. PMID 8018424 DOI: 10.1016/0959-8049(94)90451-0 |
0.035 |
|
2021 |
Smiljanić D, de Gennaro B, Daković A, Galzerano B, Germinario C, Izzo F, Rottinghaus GE, Langella A. Removal of non-steroidal anti-inflammatory drugs from water by zeolite-rich composites: The interference of inorganic anions on the ibuprofen and naproxen adsorption. Journal of Environmental Management. 286: 112168. PMID 33636624 DOI: 10.1016/j.jenvman.2021.112168 |
0.033 |
|
2008 |
Catalano O, Vallone P, Izzo F, Siani A. An inaccurate literature review and citation. Radiology. 246: 982. PMID 18309023 DOI: 10.1148/radiol.2463071311 |
0.023 |
|
1997 |
Palaia R, Izzo F, Cremona F, Ruffolo F, De Bellis M, Parisi V. Gastrojejunal reconstruction after subtotal gastrectomy using stapler devices. Personal technique. Journal of Chemotherapy (Florence, Italy). 9: 153-4. PMID 9176769 DOI: 10.1179/JOC.1997.9.2.153 |
0.02 |
|
2016 |
Di Costanzo G, Guarino M, De Stefano G, Coppola C, Tortora R, Morisco F, Angelo S, Izzo F, Nardone G, Piai G, Adinolfi L, D’Adamo G, Gaeta G, Messina V, Francica G, et al. Adherence to Guidelines in Field-Practice: Progetto Epatocarcinoma Campania Journal of Hepatology. 64: S325. DOI: 10.1016/S0168-8278(16)00448-7 |
0.01 |
|
Hide low-probability matches. |